{
  "meta": {
    "id": "test134",
    "title": "Mid Day Module (Pharma-2) - 2024-11-27",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by?",
      "options": [
        {
          "label": "A",
          "text": "Increase in heart rate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Decrease in heart rate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Increase in mean arterial pressure",
          "correct": true
        },
        {
          "label": "D",
          "text": "Decreased renal perfusion and reduced urine output",
          "correct": false
        }
      ],
      "correct_answer": "C. Increase in mean arterial pressure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Increase in mean arterial pressure</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Increase in heart rate - Not the best indicator for the efficacy of nor-epinephrine in septic shock , as the drug may actually lead to a reflex bradycardia due to increased blood pressure.</li><li>\u2022 Option A. Increase in heart rate</li><li>\u2022 Not the best indicator</li><li>\u2022 nor-epinephrine in septic shock</li><li>\u2022 reflex bradycardia due to increased blood pressure.</li><li>\u2022 Option B. Decrease in heart rate - While nor-epinephrine can cause a reflex decrease in heart rate due to increased blood pressure, it's not the primary indicator of therapeutic response in septic shock.</li><li>\u2022 Option B. Decrease in heart rate</li><li>\u2022 nor-epinephrine</li><li>\u2022 reflex decrease in heart rate</li><li>\u2022 increased blood pressure,</li><li>\u2022 not the primary indicator</li><li>\u2022 Option D. Decreased renal perfusion and reduced urine output - These are potential adverse effects of nor-epinephrine due to its vasoconstrictive action , not indicators of a positive therapeutic response.</li><li>\u2022 Option D. Decreased renal perfusion and reduced urine output</li><li>\u2022 potential adverse effects of nor-epinephrine</li><li>\u2022 vasoconstrictive action</li><li>\u2022 not</li><li>\u2022 positive therapeutic response.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The effectiveness of nor-epinephrine in the management of septic shock is best monitored by an increase in mean arterial pressure , aiming to maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg to ensure adequate organ perfusion .</li><li>\u2022 nor-epinephrine</li><li>\u2022 septic shock</li><li>\u2022 monitored</li><li>\u2022 increase in mean arterial pressure</li><li>\u2022 maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg</li><li>\u2022 adequate organ perfusion</li><li>\u2022 Ref: Harrison 19 th /1761</li><li>\u2022 Ref:</li><li>\u2022 Harrison 19 th /1761</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3c827603",
      "audio": ""
    },
    {
      "text": "A 24-year-old farm worker is rushed to a nearby emergency department after an accidental exposure to parathion. Which of the following drugs can be given to increase the activity of his acetyl cholinesterase?",
      "options": [
        {
          "label": "A",
          "text": "Atropine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dimercaprol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Physostigmine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pralidoxime",
          "correct": true
        }
      ],
      "correct_answer": "D. Pralidoxime",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Pralidoxime</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Atropine: Atropine is drug of choice as an antidote in organophosphate poisoning , but it does not increase the activity of acetylcholinesterase. Instead, it serves to counteract the effects of excess acetylcholine on muscarinic receptors , thereby relieving symptoms such as bradycardia, salivation, and bronchoconstriction. Atropine does not affect the nicotinic receptor-mediated effects (e.g., muscle weakness, paralysis).</li><li>\u2022 Option</li><li>\u2022 A.</li><li>\u2022 Atropine:</li><li>\u2022 Atropine</li><li>\u2022 drug of choice</li><li>\u2022 antidote in organophosphate poisoning</li><li>\u2022 does not increase</li><li>\u2022 acetylcholinesterase.</li><li>\u2022 serves to counteract the effects</li><li>\u2022 acetylcholine on muscarinic receptors</li><li>\u2022 bradycardia, salivation, and bronchoconstriction. Atropine does not</li><li>\u2022 nicotinic receptor-mediated</li><li>\u2022 effects (e.g., muscle weakness, paralysis).</li><li>\u2022 Option B. Dimercaprol: Dimercaprol is a chelating agent used in the treatment of poisoning by heavy metals , such as arsenic, lead, and mercury . It is not used in the treatment of organophosphate poisoning and does not i ncrease acetylcholinesterase activity .</li><li>\u2022 Option B.</li><li>\u2022 Dimercaprol:</li><li>\u2022 agent</li><li>\u2022 poisoning by heavy metals</li><li>\u2022 arsenic, lead, and mercury</li><li>\u2022 not</li><li>\u2022 organophosphate poisoning</li><li>\u2022 does not</li><li>\u2022 ncrease acetylcholinesterase activity</li><li>\u2022 Option C . Physostigmine: Physostigmine is a cholinesterase inhibitor, and unlike pralidoxime, it would exacerbate the effects of organophosphate poisoning by further inhibiting acetylcholinesterase. Therefore, it is not used in the treatment of organophosphate poisoning and is contraindicated in such cases.</li><li>\u2022 Option C</li><li>\u2022 Physostigmine:</li><li>\u2022 cholinesterase inhibitor,</li><li>\u2022 unlike pralidoxime,</li><li>\u2022 organophosphate poisoning</li><li>\u2022 inhibiting acetylcholinesterase.</li><li>\u2022 not used</li><li>\u2022 organophosphate poisoning</li><li>\u2022 contraindicated in such cases.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pralidoxime is used to reactivate acetylcholinesterase inhibited by organophosphates, thereby r educing the toxic accumulation of acetylcholine . This treatment, often used in conjunction with atropine to manage muscarinic symptoms, is critical in the management of organophosphate poisoning, highlighting the importance of specific antidotes in toxicological emergencies.</li><li>\u27a4 Pralidoxime</li><li>\u27a4 reactivate acetylcholinesterase</li><li>\u27a4 educing the toxic accumulation of</li><li>\u27a4 acetylcholine</li><li>\u27a4 conjunction with atropine to manage muscarinic symptoms,</li><li>\u27a4 organophosphate poisoning,</li><li>\u27a4 specific antidotes in toxicological emergencies.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c183dbfb",
      "audio": ""
    },
    {
      "text": "Which of the following acts on \u03b11, \u03b12 and \u03b21 receptors but does not stimulate \u03b22 receptors?",
      "options": [
        {
          "label": "A",
          "text": "Adrenaline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Noradrenaline",
          "correct": true
        },
        {
          "label": "C",
          "text": "Isoprenaline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dobutamine",
          "correct": false
        }
      ],
      "correct_answer": "B. Noradrenaline",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115834.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Noradrenaline</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Noradrenaline (norepinephrine) acts on \u03b11, \u03b12, and \u03b21 adrenergic receptors. It is a naturally occurring catecholamine that functions as a neurotransmitter and hormone in the body . Noradrenaline's action on \u03b11 and \u03b12 receptors is responsible for its vasoconstrictive effects , while its action on \u03b21 receptors affects cardiac output by increasing the heart rate and myocardial contractility. It does not stimulate \u03b22 receptors , which are primarily involved in bronchodilation and vasodilation .</li><li>\u2022 Noradrenaline (norepinephrine) acts on \u03b11, \u03b12, and \u03b21 adrenergic receptors.</li><li>\u2022 catecholamine</li><li>\u2022 neurotransmitter and hormone in the body</li><li>\u2022 \u03b11 and \u03b12 receptors</li><li>\u2022 vasoconstrictive effects</li><li>\u2022 \u03b21 receptors</li><li>\u2022 cardiac output by increasing the heart rate</li><li>\u2022 myocardial</li><li>\u2022 contractility.</li><li>\u2022 does not stimulate \u03b22 receptors</li><li>\u2022 bronchodilation and vasodilation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f21c814d",
      "audio": ""
    },
    {
      "text": "Propranolol can be used in all of the following conditions except.",
      "options": [
        {
          "label": "A",
          "text": "Thyrotoxicosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Variant angina",
          "correct": true
        },
        {
          "label": "C",
          "text": "Migraine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypertension",
          "correct": false
        }
      ],
      "correct_answer": "B. Variant angina",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/88.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Variant angina</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Thyrotoxicosis: Propranolol is used in thyrotoxicosis to provide symptomatic relief from hyperthyroid symptoms such as tachycardia, anxiety, and tremors . It can also inhibit peripheral conversion of T4 to T3.</li><li>\u2022 Option A. Thyrotoxicosis:</li><li>\u2022 Propranolol</li><li>\u2022 thyrotoxicosis</li><li>\u2022 symptomatic relief</li><li>\u2022 hyperthyroid symptoms</li><li>\u2022 tachycardia, anxiety, and tremors</li><li>\u2022 inhibit peripheral conversion of T4 to T3.</li><li>\u2022 Option C. Migraine: Propranolol is used as a prophylactic treatment for migraine . It helps reduce the frequency and severity of migraine attacks.</li><li>\u2022 Option C. Migraine:</li><li>\u2022 Propranolol</li><li>\u2022 prophylactic treatment for migraine</li><li>\u2022 reduce the frequency</li><li>\u2022 severity of</li><li>\u2022 migraine attacks.</li><li>\u2022 Option D. Hypertension: Propranolol can be used in the management of hypertension . It lowers blood pressure by reducing cardiac output and inhibiting renin release from the kidneys.</li><li>\u2022 Option D. Hypertension:</li><li>\u2022 Propranolol</li><li>\u2022 hypertension</li><li>\u2022 lowers blood pressure</li><li>\u2022 reducing cardiac</li><li>\u2022 output</li><li>\u2022 inhibiting</li><li>\u2022 renin</li><li>\u2022 kidneys.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to understand the therapeutic uses and contraindications of propranolol, a non-selective beta-blocke r. Recognizing that propranolol is contraindicated in variant angina due to its potential to worsen coronary artery spasms highlights the importance of considering the specific clinical context when selecting beta-blockers for treatment.</li><li>\u27a4 therapeutic uses</li><li>\u27a4 contraindications of propranolol,</li><li>\u27a4 non-selective beta-blocke</li><li>\u27a4 propranolol is contraindicated in variant angina</li><li>\u27a4 potential to worsen coronary artery spasms</li><li>\u27a4 Indications of \u03b2-Blockers:</li><li>\u27a4 Indications of \u03b2-Blockers:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "28d161c2",
      "audio": ""
    },
    {
      "text": "Repeated administration of a drug produces the following effect on blood pressure (as shown in the diagram). What is this phenomenon known as?",
      "options": [
        {
          "label": "A",
          "text": "Tachyphylaxis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Nicotinic actions of acetylcholine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Biphasic response of adrenaline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vasomotor reversal of Dale",
          "correct": false
        }
      ],
      "correct_answer": "A. Tachyphylaxis",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture1.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Tachyphylaxis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Nicotinic actions of acetylcholine</li><li>\u2022 Option B. Nicotinic actions of acetylcholine</li><li>\u2022 This is not the correct answer . The nicotinic actions of acetylcholine refer to the effect acetylcholine has on nicotinic acetylcholine receptors, which are ligand-gated ion channels found in the nervous system and at the neuromuscular junction . Normally acetylcholine decreases blood pressure and heart rate due to its action of muscarinic receptors. However, if we give very high dose of acetylcholine after giving atropine (to block muscarinic receptors), then it shows increase in BP and heart rate . This is due to the action of acetylcholine on nicotinic receptors present on ganglia</li><li>\u2022 not</li><li>\u2022 correct answer</li><li>\u2022 nicotinic actions</li><li>\u2022 acetylcholine</li><li>\u2022 nicotinic acetylcholine</li><li>\u2022 receptors,</li><li>\u2022 ligand-gated ion channels</li><li>\u2022 nervous system and at the neuromuscular junction</li><li>\u2022 acetylcholine decreases blood pressure and heart rate</li><li>\u2022 muscarinic receptors.</li><li>\u2022 very high dose of acetylcholine</li><li>\u2022 atropine (to block muscarinic receptors),</li><li>\u2022 increase in BP and heart rate</li><li>\u2022 acetylcholine on nicotinic receptors</li><li>\u2022 ganglia</li><li>\u2022 Option C. Biphasic response of adrenaline</li><li>\u2022 Option C. Biphasic response of adrenaline</li><li>\u2022 This option is incorrect. A biphasic response to adrenaline would involve an initial phase in which there is increase in blood pressure (due to stimulation of alpha 1 receptors) followed by a second phase in which there is fall in blood pressure (due to action on beta 2 receptors). The tracing does not show a biphasic response; it shows a series of responses that diminish over time, consistent with tachyphylaxis.</li><li>\u2022 incorrect.</li><li>\u2022 biphasic response</li><li>\u2022 adrenaline</li><li>\u2022 initial phase</li><li>\u2022 increase in blood pressure (due to stimulation of alpha 1 receptors)</li><li>\u2022 second phase</li><li>\u2022 blood pressure (due to action on beta 2 receptors).</li><li>\u2022 tracing does not</li><li>\u2022 biphasic response;</li><li>\u2022 series of responses</li><li>\u2022 diminish over time, consistent</li><li>\u2022 tachyphylaxis.</li><li>\u2022 Option D. Vasomotor reversal of Dale</li><li>\u2022 Option D. Vasomotor reversal of Dale</li><li>\u2022 Vasomotor reversal of Dale is a phenomenon where adrenaline can produce a paradoxical decrease in blood pressure due to stimulation of vasodilatory beta-adrenergic receptors , especially after pre-treatment with drugs that block alpha-adrenergic receptors. This is not what is depicted in the tracing.</li><li>\u2022 Vasomotor reversal of Dale</li><li>\u2022 adrenaline</li><li>\u2022 paradoxical decrease in blood pressure</li><li>\u2022 stimulation of vasodilatory beta-adrenergic receptors</li><li>\u2022 pre-treatment with drugs</li><li>\u2022 block alpha-adrenergic receptors.</li><li>\u2022 not</li><li>\u2022 Based on the image, the correct answer is:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Tachyphylaxis is a diminishing response to repeated administrations of the same dose of a drug over a short period. This is a common pharmacological phenomenon often seen with drugs that act on receptors or other cellular targets that can become desensitized or down-regulated with frequent stimulation .</li><li>\u2022 Tachyphylaxis is</li><li>\u2022 diminishing response</li><li>\u2022 repeated administrations</li><li>\u2022 act on receptors or other cellular targets</li><li>\u2022 desensitized or down-regulated with frequent stimulation</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4f5e6304",
      "audio": ""
    },
    {
      "text": "Which of the following patients would not benefit from the use of beta blockers?",
      "options": [
        {
          "label": "A",
          "text": "64-year-old female with frequent attacks of migraine",
          "correct": false
        },
        {
          "label": "B",
          "text": "35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors",
          "correct": false
        },
        {
          "label": "C",
          "text": "56-year-old male with erectile dysfunction",
          "correct": true
        },
        {
          "label": "D",
          "text": "74-year-old male with history of compensated heart failure",
          "correct": false
        }
      ],
      "correct_answer": "C. 56-year-old male with erectile dysfunction",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 56-year-old male with erectile dysfunction</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. 64-year-old female with frequent attacks of migraine: Beta-blockers are often used for the prophylaxis of migraines . They can help reduce the frequency and severity of migraine attacks.</li><li>\u2022 Option A. 64-year-old female with frequent attacks of migraine: Beta-blockers are often used for the prophylaxis of migraines . They can help reduce the frequency and severity of migraine attacks.</li><li>\u2022 Option A. 64-year-old female with frequent attacks of migraine:</li><li>\u2022 Beta-blockers</li><li>\u2022 prophylaxis of</li><li>\u2022 migraines</li><li>\u2022 reduce the frequency</li><li>\u2022 severity of migraine attacks.</li><li>\u2022 Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors: Beta-blockers are useful in managing symptoms of hyperthyroidism such as tachycardia and tremors by blocking the effects of excess t hyroid hormones on the heart and other tissues.</li><li>\u2022 Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors: Beta-blockers are useful in managing symptoms of hyperthyroidism such as tachycardia and tremors by blocking the effects of excess t hyroid hormones on the heart and other tissues.</li><li>\u2022 Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors:</li><li>\u2022 Beta-blockers</li><li>\u2022 useful</li><li>\u2022 hyperthyroidism</li><li>\u2022 tachycardia and tremors</li><li>\u2022 blocking the effects</li><li>\u2022 excess</li><li>\u2022 hyroid hormones on the heart and other tissues.</li><li>\u2022 Option D. 74-year-old male with history of compensated heart failure: Certain beta-blockers are indicated in the management of heart failure . They can i mprove survival and reduce the need for hospitalization in patients with heart failure, especially those with a history of compensated heart failure, provided they are carefully selected and dosed.</li><li>\u2022 Option D. 74-year-old male with history of compensated heart failure: Certain beta-blockers are indicated in the management of heart failure . They can i mprove survival and reduce the need for hospitalization in patients with heart failure, especially those with a history of compensated heart failure, provided they are carefully selected and dosed.</li><li>\u2022 Option D. 74-year-old male with history of compensated heart failure:</li><li>\u2022 beta-blockers</li><li>\u2022 heart failure</li><li>\u2022 mprove survival and reduce</li><li>\u2022 hospitalization</li><li>\u2022 heart</li><li>\u2022 failure,</li><li>\u2022 history of compensated heart failure,</li><li>\u2022 carefully selected and dosed.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to understand the indications and contraindications for beta-blocker therapy . While beta-blockers are versatile medications with a broad range of clinical applications , their potential side effects, such as exacerbating erectile dysfunction , must be considered when prescribing these drugs to ensure they align with the patient's overall health status and medical needs.</li><li>\u27a4 indications and contraindications</li><li>\u27a4 beta-blocker therapy</li><li>\u27a4 beta-blockers are versatile</li><li>\u27a4 medications</li><li>\u27a4 broad range of clinical applications</li><li>\u27a4 potential side effects,</li><li>\u27a4 exacerbating erectile dysfunction</li><li>\u27a4 prescribing these drugs to ensure they align</li><li>\u27a4 health status and medical needs.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba251c9b",
      "audio": ""
    },
    {
      "text": "A child on formoterol inhaler for treatment of bronchial asthma may exhibit all of the following features except?",
      "options": [
        {
          "label": "A",
          "text": "Tremors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hypoglycemia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hypokalemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bronchodilation",
          "correct": false
        }
      ],
      "correct_answer": "B. Hypoglycemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Hypoglycemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Tremors - A known side effect due to the stimulation of \u03b22 receptors by \u03b22 agonists.</li><li>\u2022 Option A.</li><li>\u2022 Tremors</li><li>\u2022 side effect</li><li>\u2022 \u03b22 receptors by \u03b22 agonists.</li><li>\u2022 Option C. Hypokalemia - Can occur as \u03b22 agonists increase intracellular potassium uptake .</li><li>\u2022 Option C.</li><li>\u2022 Hypokalemia</li><li>\u2022 \u03b22 agonists</li><li>\u2022 intracellular potassium uptake</li><li>\u2022 Option D. Bronchodilation - The primary therapeutic action of formoterol in bronchial asthma .</li><li>\u2022 Option D.</li><li>\u2022 Bronchodilation</li><li>\u2022 formoterol in bronchial asthma</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Formoterol, a \u03b22 agonist, does not cause hypoglycemia . Instead, it can cause side effects such as tremors, hypokalemia due to increased potassium uptake into cells , and the desired effect of bronchodilation for the management of asthma.</li><li>\u27a4 Formoterol, a \u03b22 agonist, does not</li><li>\u27a4 hypoglycemia</li><li>\u27a4 tremors, hypokalemia</li><li>\u27a4 increased potassium uptake into cells</li><li>\u27a4 bronchodilation</li><li>\u27a4 asthma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7d8dd8d",
      "audio": ""
    },
    {
      "text": "Cholinomimetic drugs can be used for the treatment of all the following conditions except ?",
      "options": [
        {
          "label": "A",
          "text": "Closed angle glaucoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bradycardia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cobra bite",
          "correct": false
        },
        {
          "label": "D",
          "text": "Myasthenia gravis",
          "correct": false
        }
      ],
      "correct_answer": "B. Bradycardia",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-120058.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Bradycardia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Correct Usage - Closed angle glaucoma : is treated with drugs like Physostigmine and Pilocarpine to increase aqueous humor outflow .</li><li>\u2022 Option A. Correct Usage - Closed angle glaucoma</li><li>\u2022 Physostigmine and Pilocarpine to increase aqueous humor outflow</li><li>\u2022 Option C. Correct Usage - For a cobra bite: Neostigmine plus atropine is used to counteract the neuromuscular blockade caused by the venom .</li><li>\u2022 Option C. Correct Usage - For a cobra bite:</li><li>\u2022 Neostigmine plus atropine</li><li>\u2022 counteract the neuromuscular blockade</li><li>\u2022 venom</li><li>\u2022 Option D. Correct Usage - In Myasthenia gravis: drugs such as Neostigmine are used to enhance neuromuscular transmission by preventing the breakdown of acetylcholine.</li><li>\u2022 Option D. Correct Usage - In Myasthenia gravis:</li><li>\u2022 Neostigmine</li><li>\u2022 neuromuscular transmission</li><li>\u2022 breakdown of acetylcholine.</li><li>\u2022 Additional Uses of Cholinergic Drugs:</li><li>\u2022 Additional Uses of Cholinergic Drugs:</li><li>\u2022 Alzheimer\u2019s disease treatment with Donepezil, Rivastigmine, and Galantamine to increase acetylcholine in the brain. Management of xerostomia with drugs like Cevimeline to stimulate salivary gland secretion . Postoperative urinary retention and paralytic ileus managed with drugs like Bethanechol and Neostigmine to stimulate the bladder detrusor muscle and GI motility . Antidote for anticholinergic poisoning with Physostigmine to counteract muscarinic receptor blockade.</li><li>\u2022 Alzheimer\u2019s disease treatment with Donepezil, Rivastigmine, and Galantamine to increase acetylcholine in the brain.</li><li>\u2022 Alzheimer\u2019s disease</li><li>\u2022 Donepezil, Rivastigmine, and Galantamine</li><li>\u2022 increase acetylcholine</li><li>\u2022 Management of xerostomia with drugs like Cevimeline to stimulate salivary gland secretion .</li><li>\u2022 xerostomia</li><li>\u2022 Cevimeline</li><li>\u2022 salivary gland secretion</li><li>\u2022 Postoperative urinary retention and paralytic ileus managed with drugs like Bethanechol and Neostigmine to stimulate the bladder detrusor muscle and GI motility .</li><li>\u2022 Postoperative urinary retention</li><li>\u2022 paralytic ileus</li><li>\u2022 Bethanechol and Neostigmine</li><li>\u2022 bladder detrusor muscle and GI motility</li><li>\u2022 Antidote for anticholinergic poisoning with Physostigmine to counteract muscarinic receptor blockade.</li><li>\u2022 Antidote for anticholinergic poisoning</li><li>\u2022 Physostigmine</li><li>\u2022 muscarinic receptor blockade.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Cholinomimetic drugs are not used for the treatment of bradycardia due to their potential to cause a decrease in heart rate . They are, however, useful in treating various other conditions where increased cholinergic action is beneficial, such as closed angle glaucoma, cobra bites, Myasthenia gravis, and Alzheimer\u2019s disease.</li><li>\u2022 Cholinomimetic drugs</li><li>\u2022 not used</li><li>\u2022 bradycardia</li><li>\u2022 decrease in heart rate</li><li>\u2022 increased cholinergic action</li><li>\u2022 closed angle glaucoma, cobra bites, Myasthenia gravis, and Alzheimer\u2019s disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5fd52a07",
      "audio": ""
    },
    {
      "text": "Treatment of choice for anaphylactic shock is",
      "options": [
        {
          "label": "A",
          "text": "Adrenaline 0.5 ml of 1:1000 solution by intramuscular route",
          "correct": true
        },
        {
          "label": "B",
          "text": "Adrenaline 1 ml of 1:10000 by intravenous route",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atropine 3 mg intravenously",
          "correct": false
        },
        {
          "label": "D",
          "text": "Adenosine 12 mg intravenously",
          "correct": false
        }
      ],
      "correct_answer": "A. Adrenaline 0.5 ml of 1:1000 solution by intramuscular route",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Adrenaline 0.5 ml of 1:1000 solution by intramuscular route</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Adrenaline 1 ml of 1 :10000 by intravenous route: This is less preferred initially due to the risk of adverse effects with intravenous administration unless absolutely necessary and under close monitoring.</li><li>\u2022 Option B. Adrenaline 1 ml of 1</li><li>\u2022 :10000 by intravenous route:</li><li>\u2022 less</li><li>\u2022 risk of adverse effects</li><li>\u2022 intravenous administration</li><li>\u2022 absolutely necessary and under close monitoring.</li><li>\u2022 Option C. Atropine 3 mg intravenously: Not used in anaphylaxis , as it does not address the pathophysiological changes involved in anaphylactic shock.</li><li>\u2022 Option C. Atropine 3 mg intravenously:</li><li>\u2022 Not used in anaphylaxis</li><li>\u2022 Option D. Adenosine 12 mg intravenously: Not indicated for anaphylaxis as it's primarily used for certain types of supraventricular tachycardias.</li><li>\u2022 Option D. Adenosine 12 mg intravenously:</li><li>\u2022 Not indicated for anaphylaxis</li><li>\u2022 used for</li><li>\u2022 supraventricular tachycardias.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 For anaphylactic shock , adrenaline is administered intramuscularly in a 1:1000 concentration as the first-line treatment . This route is preferred over subcutaneous or intravenous administration due to its effectiveness and safety profile .</li><li>\u2022 anaphylactic shock</li><li>\u2022 adrenaline</li><li>\u2022 intramuscularly in a 1:1000 concentration as the first-line treatment</li><li>\u2022 subcutaneous or intravenous administration</li><li>\u2022 effectiveness and safety profile</li><li>\u2022 Ref : Harrison 19 th /2117</li><li>\u2022 Ref : Harrison 19 th /2117</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7099d4f9",
      "audio": ""
    },
    {
      "text": "All of the following are non-selective \u03b2-blockers except:",
      "options": [
        {
          "label": "A",
          "text": "Carvedilol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Betaxolol",
          "correct": true
        },
        {
          "label": "C",
          "text": "Oxprenolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Labetalol",
          "correct": false
        }
      ],
      "correct_answer": "B. Betaxolol",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/33.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Betaxolol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Carvedilol: A non-selective beta-blocker that also has alpha-blocking activity, used for the treatment of high blood p ressure and heart failure.</li><li>\u2022 Option A.</li><li>\u2022 Carvedilol:</li><li>\u2022 non-selective beta-blocker</li><li>\u2022 alpha-blocking activity,</li><li>\u2022 high blood</li><li>\u2022 ressure and heart failure.</li><li>\u2022 Option C. Oxprenolol: A non-selective beta-blocker with intrinsic sympathomimetic activity.</li><li>\u2022 Option C.</li><li>\u2022 Oxprenolol:</li><li>\u2022 non-selective beta-blocker</li><li>\u2022 intrinsic sympathomimetic activity.</li><li>\u2022 Option D. Labetalol: A non-selective beta-blocker that also blocks alpha-1 receptors and is commonly used in pregnancy-induced hypertension.</li><li>\u2022 Option D.</li><li>\u2022 Labetalol:</li><li>\u2022 non-selective beta-blocker</li><li>\u2022 blocks alpha-1 receptors</li><li>\u2022 pregnancy-induced</li><li>\u2022 hypertension.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Betaxolol is a cardioselective beta-blocker that selectively blocks beta-1 adrenergic receptors in the heart , while Carvedilol, Oxprenolol, and Labetalol are non-selective beta-blockers affecting both beta-1 and beta-2 adrenergic receptors.</li><li>\u2022 Betaxolol</li><li>\u2022 cardioselective beta-blocker</li><li>\u2022 blocks beta-1 adrenergic receptors in the heart</li><li>\u2022 Carvedilol,</li><li>\u2022 Oxprenolol, and Labetalol</li><li>\u2022 non-selective beta-blockers</li><li>\u2022 both</li><li>\u2022 beta-1 and beta-2 adrenergic receptors.</li><li>\u2022 Cardio-selective beta blockers:</li><li>\u2022 Cardio-selective beta blockers:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1a73076",
      "audio": ""
    },
    {
      "text": "A patient present with diabetic macular edema with glaucoma. Which of the following drug should be avoided in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Alpha agonist",
          "correct": false
        },
        {
          "label": "B",
          "text": "Acetazolamide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Beta blockers",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prostaglandin analogues",
          "correct": true
        }
      ],
      "correct_answer": "D. Prostaglandin analogues",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115656.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Prostaglandin analogues</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alpha agonists: These are not primarily associated with exacerbation of macular edema .</li><li>\u2022 Option A. Alpha agonists:</li><li>\u2022 not primarily</li><li>\u2022 exacerbation of macular edema</li><li>\u2022 Option B. Acetazolamide :  A carbonic anhydrase inhibitor, not typically associated with causing or worsening macular edema .</li><li>\u2022 Option B. Acetazolamide</li><li>\u2022 carbonic anhydrase inhibitor, not</li><li>\u2022 causing or worsening macular edema</li><li>\u2022 Option C. Beta blockers: Commonly used in glaucoma to reduce intraocular pressure without affecting macular edema.</li><li>\u2022 Option C. Beta blockers:</li><li>\u2022 Commonly used in glaucoma</li><li>\u2022 reduce intraocular pressure</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Prostaglandin analogues can worsen macular edema and therefore should be avoided in patients with diabetic macular edema.</li><li>\u27a4 Prostaglandin analogues</li><li>\u27a4 worsen macular edema</li><li>\u27a4 avoided in patients with diabetic macular edema.</li><li>\u27a4 Important adverse effects of anti-glaucoma drugs</li><li>\u27a4 adverse effects of anti-glaucoma drugs</li><li>\u27a4 Ref : KDT 8 th /169</li><li>\u27a4 Ref</li><li>\u27a4 : KDT 8 th /169</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc507e9e",
      "audio": ""
    },
    {
      "text": "A pharmacological experiment was conducted to study effect of three drugs on heart rate and blood pressure. The following graphs were obtained before and after giving the drug. Which of the following statements is correct?",
      "options": [
        {
          "label": "A",
          "text": "Drug A in the graph is epinephrine",
          "correct": false
        },
        {
          "label": "B",
          "text": "The effect on heart rate in graph A can be prevented by anti-muscarinic agents",
          "correct": true
        },
        {
          "label": "C",
          "text": "Drug acting on graph B is isoprenaline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Drug acting in the graph C is nor-epinephrine",
          "correct": false
        }
      ],
      "correct_answer": "B. The effect on heart rate in graph A can be prevented by anti-muscarinic agents",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture11.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) The effect on heart rate in graph A can be prevented by anti-muscarinic agents</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Drug A in the graph can be epinephrine: This is incorrect since epinephrine usually increases heart rate due to its beta-1 stimulatory effect.</li><li>\u2022 Option A. Drug A in the graph can be epinephrine:</li><li>\u2022 incorrect</li><li>\u2022 epinephrine</li><li>\u2022 increases heart rate</li><li>\u2022 beta-1</li><li>\u2022 stimulatory effect.</li><li>\u2022 Option C. The drug acting on graph B is isoprenaline: This statement is incorrect because isoprenaline (also known as isoproterenol) is a non-selective beta-adrenergic agonist that can increase SBP but decrease DBP and MBP. Rather the graph shown is typically present in epinephrine.</li><li>\u2022 Option C. The drug acting on graph B is isoprenaline:</li><li>\u2022 incorrect</li><li>\u2022 isoprenaline (also known as isoproterenol)</li><li>\u2022 non-selective beta-adrenergic agonist</li><li>\u2022 increase SBP</li><li>\u2022 decrease DBP</li><li>\u2022 MBP.</li><li>\u2022 Option D. The drug acting in graph C is norepinephrine: This statement is incorrect because norepinephrine primarily increases SBP, DBP and MBP and cause reflex tachycardia. The graph shown is typically present in isoprenaline.</li><li>\u2022 Option D. The drug acting in graph C is norepinephrine:</li><li>\u2022 incorrect</li><li>\u2022 norepinephrine</li><li>\u2022 increases SBP,</li><li>\u2022 DBP and MBP</li><li>\u2022 reflex tachycardia.</li><li>\u2022 graph shown</li><li>\u2022 isoprenaline.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Anti-muscarinic agents can prevent the reflex bradycardia induced by vasoconstrictive drugs like norepinephrine by inhibiting the parasympathetic nervous system's control over the heart.</li><li>\u2022 Anti-muscarinic agents</li><li>\u2022 reflex bradycardia</li><li>\u2022 vasoconstrictive drugs</li><li>\u2022 norepinephrine</li><li>\u2022 parasympathetic nervous system's</li><li>\u2022 over the heart.</li><li>\u2022 Ref : Goodman and Gilman 12th/283</li><li>\u2022 Ref</li><li>\u2022 : Goodman and Gilman 12th/283</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "56a6078b",
      "audio": ""
    },
    {
      "text": "Which one of the following drugs increases gastrointestinal motility?",
      "options": [
        {
          "label": "A",
          "text": "Glycopyrrolate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atropine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Neostigmine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Fentanyl",
          "correct": false
        }
      ],
      "correct_answer": "C. Neostigmine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Neostigmine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Glycopyrrolate: Glycopyrrolate is an anticholinergic drug that decreases gastrointestinal motility. It works by blocking acetylcholine receptors in the gastrointestinal tract , reducing smooth muscle contractions and secretions . Glycopyrrolate is often used preoperatively to reduce salivary, tracheobronchial, and pharyngeal secretions .</li><li>\u2022 Option A.</li><li>\u2022 Glycopyrrolate:</li><li>\u2022 anticholinergic drug</li><li>\u2022 decreases gastrointestinal motility.</li><li>\u2022 acetylcholine receptors</li><li>\u2022 gastrointestinal tract</li><li>\u2022 reducing smooth muscle contractions and secretions</li><li>\u2022 Glycopyrrolate</li><li>\u2022 preoperatively to reduce salivary, tracheobronchial, and pharyngeal secretions</li><li>\u2022 Option B. Atropine: Atropine is another anticholinergic drug that reduces gastrointestinal motility by inhibiting the action of acetylcholine on muscarinic receptors in the gut . This results in decreased muscle tone and motility in the digestive tract. Atropine is used in various clinical settings, including pre-anesthetic medication to reduce salivation and increase heart rate.</li><li>\u2022 Option B.</li><li>\u2022 Atropine:</li><li>\u2022 anticholinergic drug</li><li>\u2022 reduces gastrointestinal motility</li><li>\u2022 acetylcholine on muscarinic receptors in the gut</li><li>\u2022 decreased muscle tone and motility</li><li>\u2022 digestive tract.</li><li>\u2022 pre-anesthetic medication</li><li>\u2022 reduce salivation and increase heart rate.</li><li>\u2022 Option D. Fentanyl: Fentanyl is a synthetic opioid analgesic, which does not directly affect gastrointestinal motility as its primary action . However, opioids , in general, are known to reduce gastrointestinal motility due to their inhibitory effects on the enteric nervous system , leading to constipation as a common side effect. Fentanyl's main use is for pain management , not for modulating gastrointestinal motility .</li><li>\u2022 Option D.</li><li>\u2022 Fentanyl:</li><li>\u2022 synthetic opioid analgesic,</li><li>\u2022 does not</li><li>\u2022 gastrointestinal motility</li><li>\u2022 its primary action</li><li>\u2022 opioids</li><li>\u2022 reduce gastrointestinal motility</li><li>\u2022 inhibitory effects</li><li>\u2022 enteric nervous system</li><li>\u2022 constipation</li><li>\u2022 Fentanyl's main</li><li>\u2022 pain management</li><li>\u2022 not for modulating gastrointestinal motility</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Neostigmine , a parasympathomimetic agent , increases gastrointestinal motility by inhibiting acetylcholinesterase and increasing acetylcholine levels . In contrast, anticholinergic drugs like glycopyrrolate and atropine decrease gastrointestinal motility by blocking acetylcholine receptors. Fentanyl, an opioid analgesic, can indirectly decrease gastrointestinal motility as a side effect of its analgesic use.</li><li>\u27a4 Neostigmine</li><li>\u27a4 parasympathomimetic agent</li><li>\u27a4 increases gastrointestinal motility</li><li>\u27a4 inhibiting acetylcholinesterase</li><li>\u27a4 increasing</li><li>\u27a4 acetylcholine levels</li><li>\u27a4 anticholinergic drugs like glycopyrrolate and atropine decrease gastrointestinal motility</li><li>\u27a4 acetylcholine receptors.</li><li>\u27a4 Fentanyl, an opioid analgesic,</li><li>\u27a4 indirectly decrease gastrointestinal motility</li><li>\u27a4 analgesic use.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "457651d6",
      "audio": ""
    },
    {
      "text": "Which of the following alpha-blocker drugs is used in the treatment of benign hypertrophy of the prostate without producing significant hypotension?",
      "options": [
        {
          "label": "A",
          "text": "Doxazosin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Phentolamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tamsulosin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Terazosin",
          "correct": false
        }
      ],
      "correct_answer": "C. Tamsulosin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Tamsulosin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Doxazosin: Doxazosin is a non-selective alpha-1 antagonist. It is used to treat hypertension and BPH , but it does not have the same degree of selectivity for the alpha-1A receptors as tamsulosin and can cause more pronounced hypotension as a side effect.</li><li>\u2022 Option A. Doxazosin:</li><li>\u2022 non-selective alpha-1 antagonist.</li><li>\u2022 hypertension and BPH</li><li>\u2022 does not</li><li>\u2022 alpha-1A receptors as tamsulosin</li><li>\u2022 pronounced hypotension</li><li>\u2022 Option B. Phentolamine: Phentolamine is a non-selective alpha-adrenergic antagonist , blocking both alpha-1 and alpha-2 receptors. It is primarily used in the management of hypertensive emergencies related to pheochromocytoma and is not commonly used in the treatment of BPH . Due to its non-selectivity, it can cause significant hypotension.</li><li>\u2022 Option B. Phentolamine:</li><li>\u2022 non-selective alpha-adrenergic antagonist</li><li>\u2022 alpha-1 and alpha-2 receptors.</li><li>\u2022 hypertensive emergencies</li><li>\u2022 pheochromocytoma</li><li>\u2022 not</li><li>\u2022 BPH</li><li>\u2022 non-selectivity,</li><li>\u2022 hypotension.</li><li>\u2022 Option D. Terazosin: Terazosin is another non-selective alpha-1 antagonist used to treat hypertension and symptoms of BPH . While it is effective in relieving urinary symptoms related to BPH, its non-selective action on alpha-1 receptors can also lead to more pronounced hypotension compared to tamsulosin.</li><li>\u2022 Option D. Terazosin:</li><li>\u2022 non-selective alpha-1 antagonist</li><li>\u2022 hypertension and symptoms of BPH</li><li>\u2022 relieving urinary symptoms</li><li>\u2022 BPH,</li><li>\u2022 non-selective</li><li>\u2022 alpha-1 receptors</li><li>\u2022 pronounced hypotension</li><li>\u2022 tamsulosin.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tamsulosin, with its selectivity for alpha-1A receptors, is preferable for treating BPH symptoms as it minimizes the risk of hypotension . In contrast, non-selective alpha-blockers like doxazosin, terazosin, and phentolamine can be used in BPH but may have a higher risk of causing hypotension .</li><li>\u27a4 Tamsulosin,</li><li>\u27a4 alpha-1A receptors,</li><li>\u27a4 BPH symptoms</li><li>\u27a4 minimizes</li><li>\u27a4 hypotension</li><li>\u27a4 non-selective alpha-blockers</li><li>\u27a4 doxazosin, terazosin, and phentolamine</li><li>\u27a4 BPH</li><li>\u27a4 higher risk</li><li>\u27a4 hypotension</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "713aff3e",
      "audio": ""
    },
    {
      "text": "In the management of anaphylactic shock, which of the following action of adrenaline is not required?",
      "options": [
        {
          "label": "A",
          "text": "Bronchodilation by beta-2 receptors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cardiovascular effects of beta-1 receptors",
          "correct": false
        },
        {
          "label": "C",
          "text": "Action on blood vessels by alpha-1 receptors",
          "correct": false
        },
        {
          "label": "D",
          "text": "Action on presynaptic alpha-2 receptors",
          "correct": true
        }
      ],
      "correct_answer": "D. Action on presynaptic alpha-2 receptors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Action on presynaptic alpha-2 receptors</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bronchodilation by beta-2 receptors is vital for reversing airway constriction in anaphylaxis .</li><li>\u2022 Option A. Bronchodilation</li><li>\u2022 beta-2 receptors</li><li>\u2022 airway constriction</li><li>\u2022 anaphylaxis</li><li>\u2022 Option B. Cardiovascular effects of beta-1 receptors are crucial for supporting heart function during shock .</li><li>\u2022 Option B. Cardiovascular</li><li>\u2022 beta-1 receptors</li><li>\u2022 heart function during shock</li><li>\u2022 Option C. Vasoconstriction by alpha-1 receptors is necessary to counteract the profound vasodilation and hypotension seen in anaphylactic shock.</li><li>\u2022 Option C. Vasoconstriction</li><li>\u2022 alpha-1 receptors</li><li>\u2022 counteract</li><li>\u2022 vasodilation and hypotension</li><li>\u2022 anaphylactic shock.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The presynaptic alpha-2 receptor action of adrenaline, which would normally inhibit norepinephrine release and dampen sympathetic responses , is not desired in the treatment of anaphylactic shock , where a strong sympathetic response is needed to combat severe allergic reactions.</li><li>\u2022 presynaptic alpha-2 receptor</li><li>\u2022 adrenaline,</li><li>\u2022 inhibit norepinephrine</li><li>\u2022 dampen</li><li>\u2022 sympathetic responses</li><li>\u2022 not</li><li>\u2022 anaphylactic shock</li><li>\u2022 strong sympathetic</li><li>\u2022 allergic reactions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c44a3aef",
      "audio": ""
    },
    {
      "text": "Which of the following is a catecholamine, that can stimulate D1, D2, alpha 1 and \u03b2-1 receptors, but not \u03b2-2 receptors?",
      "options": [
        {
          "label": "A",
          "text": "Dobutamine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dopexamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dopamine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Isoprenaline",
          "correct": false
        }
      ],
      "correct_answer": "C. Dopamine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121213.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Dopamine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Dopamine is a catecholamine neurotransmitter and hormone that exhibits activity on both dopaminergic and adrenergic receptors. It specifically stimulates D1 and D2 dopamine receptors , which are primarily involved in neurological functions and renal vasodilation , and \u03b11 and \u03b21 adrenergic receptors, which mediate vasoconstriction and increase heart rate and contractility, respectively. Importantly, dopamine does not act on \u03b22 adrenergic receptors, which are mainly responsible for bronchodilation and vasodilation .</li><li>\u2022 Dopamine</li><li>\u2022 catecholamine neurotransmitter and hormone</li><li>\u2022 both dopaminergic and adrenergic receptors.</li><li>\u2022 stimulates D1 and D2 dopamine receptors</li><li>\u2022 neurological functions</li><li>\u2022 renal vasodilation</li><li>\u2022 \u03b11 and \u03b21 adrenergic receptors,</li><li>\u2022 vasoconstriction and increase heart rate and contractility,</li><li>\u2022 dopamine does not</li><li>\u2022 \u03b22 adrenergic receptors,</li><li>\u2022 bronchodilation and vasodilation</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Dopamine is the catecholamine that meets the criteria of stimulating D1, D2, \u03b11, and \u03b21 receptors without affecting \u03b22 receptors , which is particularly relevant in treating certain cardiovascular conditions where selective receptor activation is desired</li><li>\u2022 Dopamine</li><li>\u2022 catecholamine</li><li>\u2022 D1, D2, \u03b11, and \u03b21 receptors</li><li>\u2022 \u03b22 receptors</li><li>\u2022 cardiovascular conditions</li><li>\u2022 selective receptor</li><li>\u2022 desired</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3493758",
      "audio": ""
    },
    {
      "text": "All of the following are indications of antimuscarinic drugs except ?",
      "options": [
        {
          "label": "A",
          "text": "Angle closure glaucoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Asthma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peptic ulcer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urinary incontinence",
          "correct": false
        }
      ],
      "correct_answer": "A. Angle closure glaucoma",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121431.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Angle closure glaucoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Asthma: Antimuscarinics are used to relieve bronchospasm by inhibiting constrictive parasympathetic influences on the bronchial smooth muscle.</li><li>\u2022 Option B. Asthma:</li><li>\u2022 Antimuscarinics</li><li>\u2022 used</li><li>\u2022 bronchospasm</li><li>\u2022 inhibiting constrictive parasympathetic</li><li>\u2022 bronchial smooth muscle.</li><li>\u2022 Option C. Peptic ulcer: These drugs reduce gastric acid secretion and are used to treat peptic ulcers.</li><li>\u2022 Option C. Peptic ulcer:</li><li>\u2022 reduce gastric acid secretion</li><li>\u2022 treat peptic ulcers.</li><li>\u2022 Option D. Urinary incontinence: Antimuscarinics can relax the bladder, reducing the urgency and frequency of urination.</li><li>\u2022 Option D. Urinary incontinence:</li><li>\u2022 Antimuscarinics</li><li>\u2022 relax the bladder,</li><li>\u2022 urgency and frequency of urination.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 In the treatment of various conditions where parasympathetic inhibition is beneficial, antimuscarinic drugs are indicated; however, they are contraindicated in angle-closure glaucoma due to the risk of exacerbating the condition</li><li>\u2022 parasympathetic inhibition</li><li>\u2022 beneficial, antimuscarinic drugs</li><li>\u2022 contraindicated in angle-closure glaucoma</li><li>\u2022 exacerbating the condition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1f86718b",
      "audio": ""
    },
    {
      "text": "Testing of a drug related to autonomic nervous system was planned. The drug and a placebo were administered in a healthy volunteer? The following effect were seen. What are the likely characteristics of the drug?",
      "options": [
        {
          "label": "A",
          "text": "Agonist at \u03b11 and \u03b21",
          "correct": false
        },
        {
          "label": "B",
          "text": "Agonist at \u03b11 and \u03b22",
          "correct": false
        },
        {
          "label": "C",
          "text": "Agonist at \u03b21 and \u03b22",
          "correct": true
        },
        {
          "label": "D",
          "text": "Agonist at \u03b21 and antagonist at \u03b11",
          "correct": false
        }
      ],
      "correct_answer": "C. Agonist at \u03b21 and \u03b22",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121656.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Agonist at \u03b21 and \u03b22</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Agonist at \u03b11 and \u03b21: Incorrect because \u03b11 stimulation would increase both systolic and diastolic blood pressure, which is not observed.</li><li>\u2022 Option A.  Agonist at \u03b11 and \u03b21:</li><li>\u2022 Incorrect</li><li>\u2022 \u03b11 stimulation</li><li>\u2022 increase both systolic and diastolic blood pressure,</li><li>\u2022 Option B. Agonist at \u03b11 and \u03b22: Incorrec t because \u03b11 agonist action would not result in decreased diastolic blood pressure.</li><li>\u2022 Option B. Agonist at \u03b11 and \u03b22:</li><li>\u2022 Incorrec</li><li>\u2022 \u03b11 agonist action</li><li>\u2022 not</li><li>\u2022 decreased diastolic blood pressure.</li><li>\u2022 Option D.  Agonist at \u03b21 and antagonist at \u03b11: Incorrect because an \u03b11 antagonist would lead to a decrease in both systolic and diastolic blood pressure, not an increase in systolic pressure.</li><li>\u2022 Option D.  Agonist at \u03b21 and antagonist at \u03b11:</li><li>\u2022 Incorrect</li><li>\u2022 \u03b11 antagonist</li><li>\u2022 decrease in both systolic and diastolic blood pressure, not an increase in systolic pressure.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The characteristic effects of tachycardia and changes in blood pressure, along with the presence of tremors , suggest that the drug has agonistic activity at \u03b21 and \u03b22 receptors, making it a likely candidate for a beta-adrenergic agonist with both cardiac and peripheral actions.</li><li>\u2022 tachycardia and changes in blood pressure,</li><li>\u2022 presence of tremors</li><li>\u2022 agonistic activity at \u03b21 and \u03b22 receptors,</li><li>\u2022 beta-adrenergic agonist</li><li>\u2022 both cardiac and</li><li>\u2022 peripheral actions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb394694",
      "audio": ""
    },
    {
      "text": "A patient presents to emergency with pinpoint pupil, salivation, lacrimation, tremors and red tears. Plasma cholinesterase level was 30% of normal. Most probable Diagnosis is?",
      "options": [
        {
          "label": "A",
          "text": "Organophosphate poisoning",
          "correct": true
        },
        {
          "label": "B",
          "text": "Dhatura poisoning",
          "correct": false
        },
        {
          "label": "C",
          "text": "Opioid poisoning",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pontine hemorrhage",
          "correct": false
        }
      ],
      "correct_answer": "A. Organophosphate poisoning",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Organophosphate poisoning</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Dhatura poisoning: Dhatura , a plant containing anticholinergic tropane alkaloids (e.g., atropine, scopolamine ), would cause anticholinergic syndrome , characterized by dry skin and mucous membranes, flushed face, hyperthermia, mydriasis (dilated pupils), and hallucinations. This is opposite to the cholinergic signs seen in the patient.</li><li>\u2022 Option B. Dhatura poisoning:</li><li>\u2022 Dhatura</li><li>\u2022 plant</li><li>\u2022 anticholinergic tropane alkaloids</li><li>\u2022 atropine, scopolamine</li><li>\u2022 anticholinergic syndrome</li><li>\u2022 dry skin and mucous membranes, flushed face, hyperthermia, mydriasis (dilated pupils), and hallucinations.</li><li>\u2022 opposite to the cholinergic signs</li><li>\u2022 Option C. Opioid poisoning: Opioid poisoning can cause pinpoint pupils , but the predominant symptoms would also include respiratory depression and decreased level of consciousness , which are not mentioned in the scenario. Opioids do not cause excessive salivation or lacrimation , nor do they affect plasma cholinesterase levels.</li><li>\u2022 Option C. Opioid poisoning:</li><li>\u2022 pinpoint pupils</li><li>\u2022 respiratory depression and decreased level of consciousness</li><li>\u2022 Opioids do not</li><li>\u2022 excessive salivation or lacrimation</li><li>\u2022 plasma cholinesterase levels.</li><li>\u2022 Option D. Pontine hemorrhage: While pontine hemorrhage can lead to pinpoint pupils due to disruption of the sympathetic pathways , it would also typically present with acute neurological deficits like altered consciousness, paralysis, or other focal neurological signs , which are not described in this scenario. Additionally, pontine hemorrhage would not explain the reduced plasma cholinesterase levels or the specific combination of symptoms mentioned.</li><li>\u2022 Option D. Pontine hemorrhage:</li><li>\u2022 pinpoint pupils</li><li>\u2022 sympathetic pathways</li><li>\u2022 acute neurological deficits like altered consciousness, paralysis, or other focal neurological signs</li><li>\u2022 pontine hemorrhage</li><li>\u2022 not explain</li><li>\u2022 reduced plasma cholinesterase levels</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational objective is to recognize the clinical presentation of organophosphate poisoning, which includes signs of cholinergic excess such as miosis, excessive salivation, lacrimation, and muscle tremors, along with reduced plasma cholinesterase levels . Understanding the clinical features and laboratory findings associated with this condition is critical for prompt diagnosis and treatment .</li><li>\u27a4 clinical presentation of organophosphate poisoning,</li><li>\u27a4 cholinergic</li><li>\u27a4 miosis, excessive salivation, lacrimation, and muscle tremors,</li><li>\u27a4 reduced plasma cholinesterase levels</li><li>\u27a4 Understanding the clinical features and laboratory findings</li><li>\u27a4 prompt diagnosis and treatment</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bd29e682",
      "audio": ""
    },
    {
      "text": "A 55-year-old man came with urinary symptoms of increased frequency and hesitation. The patient was diagnosed with benign hyperplasia of prostate. Which of the drugs will help to prevent further growth and possibly reduces the size of the prostate?",
      "options": [
        {
          "label": "A",
          "text": "Tamsulosin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Finasteride",
          "correct": true
        },
        {
          "label": "C",
          "text": "Prazosin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Testosterone",
          "correct": false
        }
      ],
      "correct_answer": "B. Finasteride",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Finasteride</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Tamsulosin: This medication is an alpha-1A antagonist that relaxes the muscles in the prostate and bladder neck, improving urine flow, but does not affect prostate size.</li><li>\u2022 Option A. Tamsulosin:</li><li>\u2022 alpha-1A antagonist</li><li>\u2022 relaxes the muscles</li><li>\u2022 prostate and bladder neck,</li><li>\u2022 improving urine flow,</li><li>\u2022 does not</li><li>\u2022 prostate size.</li><li>\u2022 Option C. Prazosin: While this non-selective alpha-1 antagonist can improve symptoms of benign prostatic hyperplasia (BPH ) by relaxing prostate and bladder neck muscles, it doesn't reduce prostate size and is noted for causing postural hypotension.</li><li>\u2022 Option C. Prazosin:</li><li>\u2022 non-selective alpha-1 antagonist</li><li>\u2022 benign prostatic hyperplasia (BPH</li><li>\u2022 relaxing prostate and bladder neck muscles,</li><li>\u2022 doesn't reduce prostate size</li><li>\u2022 causing postural hypotension.</li><li>\u2022 Option D. Testosterone: Administration of testosterone can actually exacerbate BPH due to its conversion to DHT within the prostate, leading to further growth.</li><li>\u2022 Option D. Testosterone:</li><li>\u2022 exacerbate BPH</li><li>\u2022 conversion to DHT</li><li>\u2022 prostate,</li><li>\u2022 further growth.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For a patient diagnosed with BPH, finasteride is the drug of choice to not only alleviate urinary symptoms but also potentially reduce prostate size due to its mechanism of inhibiting the enzyme 5-alpha reductase and lowering intraprostatic DHT levels.</li><li>\u27a4 BPH, finasteride</li><li>\u27a4 drug of choice</li><li>\u27a4 alleviate urinary symptoms</li><li>\u27a4 reduce prostate size</li><li>\u27a4 inhibiting the enzyme 5-alpha reductase</li><li>\u27a4 lowering intraprostatic DHT levels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c377ca38",
      "audio": ""
    },
    {
      "text": "After eating a plant as shown in the figure below, A child presented to emergency in comatose state. The pupils were dilated, and skin was dry. Body temperature is raised, and heart rate is high. These signs and symptoms can occur with the intake of which of the following substance?",
      "options": [
        {
          "label": "A",
          "text": "Morphine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Quinine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Atropine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Digoxin",
          "correct": false
        }
      ],
      "correct_answer": "C. Atropine",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture3_XXE4pf8.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Atropine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  Morphine - Incorrect, as morphine typically causes constricted pupils (miosis), not dilation.</li><li>\u2022 Option A.  Morphine</li><li>\u2022 - Incorrect,</li><li>\u2022 constricted pupils (miosis),</li><li>\u2022 Option B. Quinine - Incorrect, as quinine is not commonly associated with these symptoms.</li><li>\u2022 Option B. Quinine</li><li>\u2022 Incorrect,</li><li>\u2022 not</li><li>\u2022 these symptoms.</li><li>\u2022 Option D.  Digoxin - Incorrect, as digoxin overdose typically does not cause hyperthermia and dry skin but can cause other symptoms such as nausea, vomiting, and heart rhythm disturbances.</li><li>\u2022 Option D.  Digoxin</li><li>\u2022 Incorrect,</li><li>\u2022 digoxin overdose</li><li>\u2022 does not cause hyperthermia</li><li>\u2022 dry skin</li><li>\u2022 nausea, vomiting, and heart rhythm disturbances.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The DHATURA acronym can be used to remember the signs of atropine poisoning: Dry mouth and Delirium, Hyperthermia, Agitation, Tachycardia, Urinary retention, Retention of stool, and lost Accommodation (dilated pupils, photophobia, blurred vision).</li><li>\u2022 DHATURA acronym</li><li>\u2022 signs of atropine poisoning: Dry mouth and Delirium, Hyperthermia, Agitation, Tachycardia, Urinary retention, Retention of stool, and lost Accommodation (dilated pupils, photophobia, blurred vision).</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fa094ad0",
      "audio": ""
    },
    {
      "text": "Which of the following is the shortest acting mydriatic drug?",
      "options": [
        {
          "label": "A",
          "text": "Atropine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tropicamide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cyclopentolate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Homatropine",
          "correct": false
        }
      ],
      "correct_answer": "B. Tropicamide",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122143.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Tropicamide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Atropine - Incorrect because atropine has a very long duration of action in the eye, ranging from 7-14 days.</li><li>\u2022 Option A. Atropine</li><li>\u2022 Incorrect</li><li>\u2022 atropine has a very long duration of action</li><li>\u2022 7-14 days.</li><li>\u2022 Option C. Cyclopentolate - Incorrect as it has a slower onset of action and a longer duration than tropicamide.</li><li>\u2022 Option C. Cyclopentolate</li><li>\u2022 Incorrect</li><li>\u2022 slower onset of action</li><li>\u2022 longer duration</li><li>\u2022 tropicamide.</li><li>\u2022 Option D. Homatropine - Incorrect because it does not act as rapidly as tropicamide and has a longer duration of action.</li><li>\u2022 Option D. Homatropine</li><li>\u2022 Incorrect</li><li>\u2022 does not</li><li>\u2022 rapidly as tropicamide</li><li>\u2022 longer duration of action.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Tropicamide is the preferred mydriatic agen t for fundus examination due to its short acting duration , which is generally around 4-6 hours . It is especially useful over other anticholinergic agents when a quick return to normal pupil size is desired, such as in outpatient settings.</li><li>\u2022 Tropicamide</li><li>\u2022 mydriatic agen</li><li>\u2022 short acting duration</li><li>\u2022 4-6</li><li>\u2022 hours</li><li>\u2022 useful over other anticholinergic agents</li><li>\u2022 quick return to normal pupil size</li><li>\u2022 outpatient settings.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "18bd73f2",
      "audio": ""
    },
    {
      "text": "Which of the following is an antimuscarinic drug useful in overactive bladder?",
      "options": [
        {
          "label": "A",
          "text": "Pirenzepine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tolterodine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Tropicamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Atropine",
          "correct": false
        }
      ],
      "correct_answer": "B. Tolterodine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.\u00a0 B) Tolterodine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pirenzepine: Pirenzepine is primarily used as a selective M1 muscarinic receptor antagonist in the treatment of peptic ulcers. It is not indicated for the treatment of overactive bladder.</li><li>\u2022 Option</li><li>\u2022 A. Pirenzepine:</li><li>\u2022 selective M1 muscarinic receptor antagonist</li><li>\u2022 peptic</li><li>\u2022 ulcers.</li><li>\u2022 not indicated</li><li>\u2022 overactive bladder.</li><li>\u2022 Option C. Tropicamide: Tropicamide is a muscarinic receptor antagonist used as a mydriatic agent to induce pupillary dilation for ophthalmic examinations. It is not indicated for the treatment of overactive bladder.</li><li>\u2022 Option C.</li><li>\u2022 Tropicamide:</li><li>\u2022 muscarinic receptor antagonist</li><li>\u2022 mydriatic agent</li><li>\u2022 pupillary dilation</li><li>\u2022 ophthalmic examinations.</li><li>\u2022 not indicated</li><li>\u2022 overactive bladder.</li><li>\u2022 Option D. Atropine: Atropine is a non-selective muscarinic receptor antagonist used for various purposes, including the treatment of bradycardia, organophosphate poisoning, and as a preanesthetic medication . While it can reduce detrusor muscle activity , it is not commonly used for the treatment of overactive bladder due to its non-selective nature and potential side effects.</li><li>\u2022 Option D.</li><li>\u2022 Atropine:</li><li>\u2022 non-selective muscarinic receptor antagonist</li><li>\u2022 treatment of bradycardia, organophosphate poisoning,</li><li>\u2022 preanesthetic medication</li><li>\u2022 reduce detrusor muscle activity</li><li>\u2022 not</li><li>\u2022 treatment of overactive bladder</li><li>\u2022 non-selective nature and potential side effects.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tolterodine, as an antimuscarinic agent, is commonly used in the treatment of overactive bladder due to its ability to reduce urinary frequency, urgency, and urge incontinence by blocking muscarinic receptors in the bladder.</li><li>\u27a4 Tolterodine,</li><li>\u27a4 antimuscarinic agent,</li><li>\u27a4 treatment of overactive bladder</li><li>\u27a4 ability to reduce urinary frequency, urgency, and urge incontinence</li><li>\u27a4 blocking muscarinic receptors</li><li>\u27a4 bladder.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a8304509",
      "audio": ""
    },
    {
      "text": "Which is the new \u03b23 agonist approved for overactive bladder?",
      "options": [
        {
          "label": "A",
          "text": "Fesoterodine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Trospium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mirabegron",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oxybutynin",
          "correct": false
        }
      ],
      "correct_answer": "C. Mirabegron",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Mirabegron</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Fesoterodine - Incorrect , it is an antimuscarinic agent used for overactive bladder but not a \u03b23 agonist.</li><li>\u2022 Option A. Fesoterodine</li><li>\u2022 Incorrect</li><li>\u2022 antimuscarinic agent</li><li>\u2022 overactive bladder</li><li>\u2022 not a \u03b23 agonist.</li><li>\u2022 Option B. Trospium - Incorrect , also an antimuscarinic , not a \u03b23 agonist .</li><li>\u2022 Option B. Trospium</li><li>\u2022 Incorrect</li><li>\u2022 antimuscarinic</li><li>\u2022 not a \u03b23 agonist</li><li>\u2022 Option D. Oxybutynin - Incorrect, this is an older antimuscarinic drug used for overactive bladder .</li><li>\u2022 Option D. Oxybutynin</li><li>\u2022 - Incorrect,</li><li>\u2022 older antimuscarinic drug</li><li>\u2022 overactive bladder</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Mirabegron is the first \u03b23 agonist approved for the treatment of overactive bladder, offering a mechanism of action different from antimuscarinic agents, and can be an option for patients who cannot tolerate or do not respond to anticholinergic medications.</li><li>\u2022 Mirabegron</li><li>\u2022 first \u03b23 agonist</li><li>\u2022 overactive bladder,</li><li>\u2022 mechanism of action different</li><li>\u2022 antimuscarinic agents,</li><li>\u2022 cannot tolerate</li><li>\u2022 do not respond to anticholinergic medications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b710c98c",
      "audio": ""
    },
    {
      "text": "Propranolol is useful in the treatment of all of the following EXCEPT?",
      "options": [
        {
          "label": "A",
          "text": "Angina",
          "correct": false
        },
        {
          "label": "B",
          "text": "Partial atrioventricular block",
          "correct": true
        },
        {
          "label": "C",
          "text": "Idiopathic hypertrophic subaortic cardiomyopathy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Familial tremor",
          "correct": false
        }
      ],
      "correct_answer": "B. Partial atrioventricular block",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Partial atrioventricular block</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Angina: Propranolol is used in the management of angina pectoris due to its ability to reduce myocardial oxygen demand .</li><li>\u2022 Option A. Angina:</li><li>\u2022 Propranolol</li><li>\u2022 angina pectoris</li><li>\u2022 ability to reduce myocardial oxygen demand</li><li>\u2022 Option C. Idiopathic: hypertrophic subaortic cardiomyopathy (HOCM): Beta blockers like propranolol are used in HOCM to reduce the outflow obstruction and improve symptoms.</li><li>\u2022 Option C. Idiopathic:</li><li>\u2022 hypertrophic subaortic cardiomyopathy (HOCM):</li><li>\u2022 propranolol</li><li>\u2022 HOCM to reduce</li><li>\u2022 outflow obstruction</li><li>\u2022 improve symptoms.</li><li>\u2022 Option D. Familial tremor: Propranolol is effective in reducing tremors in conditions like familial or essential tremor.</li><li>\u2022 Option D. Familial tremor:</li><li>\u2022 Propranolol</li><li>\u2022 reducing tremors</li><li>\u2022 familial or essential tremor.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Propranolol is contraindicated in patients with partial atrioventricular block as it can exacerbate the condition leading to complete heart block. It is, however, beneficial in conditions such as angina, HOCM, and familial tremors . Patients with variant angina (Prinzmetal's angina) should not be treated with propranolol due to the risk of coronary vasospasm.</li><li>\u2022 Propranolol</li><li>\u2022 contraindicated</li><li>\u2022 partial atrioventricular block</li><li>\u2022 exacerbate the condition</li><li>\u2022 complete</li><li>\u2022 heart block.</li><li>\u2022 beneficial</li><li>\u2022 angina, HOCM, and familial tremors</li><li>\u2022 variant angina</li><li>\u2022 (Prinzmetal's angina)</li><li>\u2022 should not</li><li>\u2022 propranolol due to the risk of coronary vasospasm.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5de48d70",
      "audio": ""
    },
    {
      "text": "Muscarinic receptor stimulation primarily causes which of the following actions?",
      "options": [
        {
          "label": "A",
          "text": "Erection",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ejaculation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dilation of bronchus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased cardiac contractility",
          "correct": false
        }
      ],
      "correct_answer": "A. Erection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Erection</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Ejaculation: This is primarily a function of the sympathetic nervous system, not muscarinic receptor stimulation.</li><li>\u2022 Option B. Ejaculation:</li><li>\u2022 Option C. Dilation of bronchus: Muscarinic receptor stimulation actually leads to bronchoconstriction, not dilation. The dilation of bronchi is mediated by the sympathetic nervous system through \u03b22-adrenergic receptors.</li><li>\u2022 Option C. Dilation of bronchus:</li><li>\u2022 Option D. Increased cardiac contractility: This is mainly mediated by \u03b21-adrenergic receptors under the influence of the sympathetic nervous system. Muscarinic receptor stimulation can decrease heart rate but does not directly increase contractility.</li><li>\u2022 Option D. Increased cardiac contractility:</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The parasympathetic nervous system, through muscarinic receptor stimulation, primarily causes erection due to vasodilation in erectile tissues, contrasting with the sympathetic nervous system's role in ejaculation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef05857b",
      "audio": ""
    },
    {
      "text": "Anti-glaucoma drug that acts by increasing uveoscleral outflow is:",
      "options": [
        {
          "label": "A",
          "text": "Latanoprost",
          "correct": true
        },
        {
          "label": "B",
          "text": "Timolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dorzolamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pilocarpine",
          "correct": false
        }
      ],
      "correct_answer": "A. Latanoprost",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/99.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Latanoprost</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Timolol: Timolol is a beta-blocke r used in the treatment of glaucoma, but it works by decreasing aqueous humor production in the eye, not by increasing uveoscleral outflow.</li><li>\u2022 Option B. Timolol: Timolol is a beta-blocke r used in the treatment of glaucoma, but it works by decreasing aqueous humor production in the eye, not by increasing uveoscleral outflow.</li><li>\u2022 Option B. Timolol:</li><li>\u2022 beta-blocke</li><li>\u2022 treatment of glaucoma,</li><li>\u2022 decreasing aqueous</li><li>\u2022 humor production in the eye,</li><li>\u2022 Option C. Dorzolamide: Dorzolamide is a carbonic anhydrase inhibitor that also reduces intraocular pressure by decreasing aqueous humor production . It does not act by increasing uveoscleral outflow.</li><li>\u2022 Option C. Dorzolamide: Dorzolamide is a carbonic anhydrase inhibitor that also reduces intraocular pressure by decreasing aqueous humor production . It does not act by increasing uveoscleral outflow.</li><li>\u2022 Option C. Dorzolamide:</li><li>\u2022 Dorzolamide is a carbonic anhydrase inhibitor</li><li>\u2022 reduces intraocular pressure</li><li>\u2022 decreasing aqueous humor production</li><li>\u2022 Option D. Pilocarpine: Pilocarpine is a muscarinic agonist that reduces i ntraocular pressure by increasing the outflow of aqueous humor through the trabecular meshwork, which is different from increasing uveoscleral outflow.</li><li>\u2022 Option D. Pilocarpine: Pilocarpine is a muscarinic agonist that reduces i ntraocular pressure by increasing the outflow of aqueous humor through the trabecular meshwork, which is different from increasing uveoscleral outflow.</li><li>\u2022 Option D. Pilocarpine:</li><li>\u2022 Pilocarpine is a muscarinic agonist</li><li>\u2022 ntraocular pressure by increasing the outflow of</li><li>\u2022 aqueous humor</li><li>\u2022 trabecular meshwork,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to recognize the mechanism of action of different anti-glaucoma medications , particularly identifying latanoprost as a drug that reduces intraocular pressure by increasing uveoscleral outflow. Understanding how various anti-glaucoma drugs work is essential for selecting appropriate treatment options based on the individual needs and pathophysiology of the patient's glaucoma.</li><li>\u27a4 mechanism of action</li><li>\u27a4 anti-glaucoma medications</li><li>\u27a4 latanoprost as</li><li>\u27a4 reduces intraocular pressure</li><li>\u27a4 increasing uveoscleral outflow.</li><li>\u27a4 anti-glaucoma</li><li>\u27a4 Mechanism of action of anti-glaucoma drugs</li><li>\u27a4 Mechanism of action of anti-glaucoma drugs</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "812e4c43",
      "audio": ""
    },
    {
      "text": "A patient presented with acute glaucoma and painful red eye. Intraocular pressure was 38 mmHg. Slit lamp examination showed aqueous flare and keratic precipitates. Which of the following drugs should not be given in this patient for the control of glaucoma?",
      "options": [
        {
          "label": "A",
          "text": "Beta blockers",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mannitol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Acetazolamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prostaglandin analogues",
          "correct": true
        }
      ],
      "correct_answer": "D. Prostaglandin analogues",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Prostaglandin analogues</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option Beta blockers (A. Beta blockers) reduce intraocular pressure by decreasing the production of aqueous humor. They do not directly address inflammation but can be used in conjunction with anti-inflammatory treatments.</li><li>\u2022 Option Beta blockers (A. Beta blockers) reduce intraocular pressure by decreasing the production of aqueous humor. They do not directly address inflammation but can be used in conjunction with anti-inflammatory treatments.</li><li>\u2022 Option Beta blockers</li><li>\u2022 reduce intraocular pressure</li><li>\u2022 decreasing</li><li>\u2022 aqueous humor.</li><li>\u2022 do not</li><li>\u2022 inflammation</li><li>\u2022 conjunction</li><li>\u2022 anti-inflammatory treatments.</li><li>\u2022 Option Mannitol (B. Mannitol), an osmotic diuretic , can rapidly reduce intraocular pressure by drawing fluid out of the eye, including in acute settings. It does not worsen the underlying inflammation.</li><li>\u2022 Option Mannitol (B. Mannitol), an osmotic diuretic , can rapidly reduce intraocular pressure by drawing fluid out of the eye, including in acute settings. It does not worsen the underlying inflammation.</li><li>\u2022 Option Mannitol</li><li>\u2022 osmotic diuretic</li><li>\u2022 rapidly reduce intraocular pressure</li><li>\u2022 drawing fluid out</li><li>\u2022 eye,</li><li>\u2022 acute settings.</li><li>\u2022 does not</li><li>\u2022 underlying inflammation.</li><li>\u2022 Option Acetazolamide (C. Acetazolamide) reduces aqueous humor production and, consequently, ientraocular pressure. These does not worsen inflammation and is used as part of a broader treatment regimen.</li><li>\u2022 Option Acetazolamide (C. Acetazolamide) reduces aqueous humor production and, consequently, ientraocular pressure. These does not worsen inflammation and is used as part of a broader treatment regimen.</li><li>\u2022 Option Acetazolamide</li><li>\u2022 reduces aqueous humor production</li><li>\u2022 ientraocular pressure.</li><li>\u2022 does not</li><li>\u2022 inflammation</li><li>\u2022 broader treatment regimen.</li><li>\u2022 For managing uveitis specifically, treatment often includes corticosteroids (either topical, periocular, or systemic) to reduce inflammation and immunosuppressive agent s in more severe cases . It\u2019s important to treat both the inflammation caused by uveitis and the elevated intraocular pressure to prevent vision loss.</li><li>\u2022 For managing uveitis</li><li>\u2022 treatment</li><li>\u2022 corticosteroids (either topical, periocular, or systemic)</li><li>\u2022 reduce</li><li>\u2022 inflammation and immunosuppressive agent</li><li>\u2022 more severe cases</li><li>\u2022 both the inflammation</li><li>\u2022 uveitis</li><li>\u2022 elevated intraocular pressure to prevent vision loss.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The presence of uveitis in a patient with glaucoma significantly impacts the choice of treatment. Understanding the need to manage intraocular pressure while also addressing ocular inflammation is crucial. The goal is to select a treatment regimen that effectively lowers intraocular pressure without exacerbating uveitis , highlighting the importance of a comprehensive approach to patient care that considers the complexities introduced by overlapping ocular conditions.</li><li>\u27a4 presence of uveitis</li><li>\u27a4 glaucoma</li><li>\u27a4 impacts</li><li>\u27a4 manage</li><li>\u27a4 intraocular pressure</li><li>\u27a4 ocular inflammation is crucial.</li><li>\u27a4 lowers intraocular pressure without exacerbating uveitis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "869b3eba",
      "audio": ""
    },
    {
      "text": "In a dog blood pressure experiment, a researcher injected phentolamine first followed by epinephrine and the recordings of the effect are shown in the diagram given below. This phenomenon is known as?",
      "options": [
        {
          "label": "A",
          "text": "Tachyphylaxis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Biphasic response of epinephrine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Vasomotor reversal of Dale",
          "correct": true
        },
        {
          "label": "D",
          "text": "Phentolamine epinephrine coupling",
          "correct": false
        }
      ],
      "correct_answer": "C. Vasomotor reversal of Dale",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/6.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Vasomotor reversal of Dale</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10fd511f",
      "audio": ""
    },
    {
      "text": "A 60-year-old female with a history of glaucoma presents to the ophthalmologist with complaints of blurred vision and eye irritation. The patient reports that she has been using an anti-glaucoma medication for the past six months, and her symptoms began to appear gradually over the past few weeks. Appearance of eye is as shown in the figure. Which of the following anti-glaucoma drugs is likely to produce this adverse effect?",
      "options": [
        {
          "label": "A",
          "text": "Timolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Latanoprost",
          "correct": true
        },
        {
          "label": "C",
          "text": "Brimonidine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dorzolamide",
          "correct": false
        }
      ],
      "correct_answer": "B. Latanoprost",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160127.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Latanoprost.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2d6647af",
      "audio": ""
    },
    {
      "text": "A new biological therapy, Anakinra has been developed for treatment of Rheumatoid Arthritis. What is the mechanism of action of anakinra?",
      "options": [
        {
          "label": "A",
          "text": "TNF antagonist",
          "correct": false
        },
        {
          "label": "B",
          "text": "IL-1 antagonist",
          "correct": true
        },
        {
          "label": "C",
          "text": "IL-2 antagonist",
          "correct": false
        },
        {
          "label": "D",
          "text": "IL-6 antagonist",
          "correct": false
        }
      ],
      "correct_answer": "B. IL-1 antagonist",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) IL-1 antagonist</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. TNF antagonist: This option is incorrect. TNF antagonists are a class of biologics that include drugs such as infliximab , etanercept , and adalimumab . They work by inhibiting the action of tumor necrosis factor-alpha (TNF-alpha), not IL-1.</li><li>\u2022 Option A. TNF antagonist:</li><li>\u2022 TNF antagonists</li><li>\u2022 class of biologics</li><li>\u2022 drugs such as infliximab</li><li>\u2022 etanercept</li><li>\u2022 adalimumab</li><li>\u2022 Option C. IL-2 antagonist: This option is incorrect. IL-2 antagonists , such as basiliximab and daclizumab , are used primarily to prevent rejection in organ transplantation by inhibiting the action of interleukin-2 (IL-2), which is different from the mechanism of action of anakinra.</li><li>\u2022 Option C. IL-2 antagonist:</li><li>\u2022 IL-2 antagonists</li><li>\u2022 basiliximab and daclizumab</li><li>\u2022 prevent rejection</li><li>\u2022 organ transplantation</li><li>\u2022 inhibiting the action of interleukin-2</li><li>\u2022 Option D. IL-6 antagonist: This option is incorrect. IL-6 antagonists , such as tocilizumab and sarilumab , are used in the treatment of rheumatoid arthritis by inhibiting the action of interleukin-6 (IL-6), a different pathway from that targeted by anakinra.</li><li>\u2022 Option D. IL-6 antagonist:</li><li>\u2022 IL-6 antagonists</li><li>\u2022 tocilizumab and sarilumab</li><li>\u2022 treatment of rheumatoid arthritis</li><li>\u2022 inhibiting the action of interleukin-6</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to understand the specific mechanism of action of anakinra in the treatment of rheumatoid arthritis . Recognizing anakinra as an IL-1 antagonist is crucial for understanding its role in managing inflammation and joint damage in patients with rheumatoid arthritis, highlighting the importance of targeted biological therapies in modulating specific pathways involved in the disease process.</li><li>\u27a4 understand the specific mechanism of action of anakinra</li><li>\u27a4 treatment of rheumatoid arthritis</li><li>\u27a4 Recognizing anakinra</li><li>\u27a4 IL-1 antagonist</li><li>\u27a4 role in managing inflammation</li><li>\u27a4 joint damage</li><li>\u27a4 rheumatoid arthritis,</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dc0d1ec0",
      "audio": ""
    },
    {
      "text": "Which of the following Disease modifying anti- rheumatoid drugs acts by causing extracellular accumulation of adenosine?",
      "options": [
        {
          "label": "A",
          "text": "Leflunomide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Azathioprine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hydroxychloroquine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methotrexate",
          "correct": true
        }
      ],
      "correct_answer": "D. Methotrexate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture1.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Methotrexate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Leflunomide: Leflunomide is an inhibitor of dihydroorotate dehydrogenase , an enzyme involved in the de novo synthesis of pyrimidine. It does not directly affect adenosine levels.</li><li>\u2022 Option A. Leflunomide:</li><li>\u2022 inhibitor of dihydroorotate dehydrogenase</li><li>\u2022 Option B. Azathioprine: Azathioprine is a prodrug that is converted to 6-mercaptopurine (6-MP), which inhibits purine synthesis by acting as a purine analogue . It does not directly affect adenosine levels.</li><li>\u2022 Option B. Azathioprine:</li><li>\u2022 prodrug that is converted to 6-mercaptopurine</li><li>\u2022 inhibits purine synthesis</li><li>\u2022 acting as a purine analogue</li><li>\u2022 Option C. Hydroxychloroquine: Hydroxychloroquine exerts its effects by inhibiting lysosomal acidification , antigen presentation , and Toll-like receptor signaling . It does not directly affect adenosine levels.</li><li>\u2022 Option C. Hydroxychloroquine:</li><li>\u2022 exerts its effects by inhibiting lysosomal acidification</li><li>\u2022 antigen presentation</li><li>\u2022 Toll-like receptor signaling</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Methotrexate increases extracellular adenosine levels by inhibiting enzymes involved in de novo purine synthesis , which contributes to its anti-inflammatory effects in the treatment of Rheumatoid Arthritis .</li><li>\u2022 Methotrexate increases extracellular adenosine levels</li><li>\u2022 inhibiting enzymes</li><li>\u2022 de novo purine synthesis</li><li>\u2022 anti-inflammatory effects</li><li>\u2022 treatment of Rheumatoid Arthritis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4a87cfc5",
      "audio": ""
    },
    {
      "text": "A highway truck driver has profuse rhinorrhea and sneezing. Which amongst the following drugs would you prescribe him?",
      "options": [
        {
          "label": "A",
          "text": "Pheniramine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Promethazine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dimehydrinate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cetirizine",
          "correct": true
        }
      ],
      "correct_answer": "D. Cetirizine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Cetirizine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Pheniramine: Pheniramine is a first-generation antihistamine that can effectively relieve allergic symptoms but is known to cause sedation as a side effect , which can impair driving ability and alertness.</li><li>\u2022 Option A. Pheniramine:</li><li>\u2022 first-generation antihistamine</li><li>\u2022 relieve allergic symptoms</li><li>\u2022 cause sedation as a side effect</li><li>\u2022 Option B. Promethazine: Promethazine is another first-generation antihistamine with strong sedative properties, making it unsuitable for individuals who need to remain alert, such as drivers.</li><li>\u2022 Option B. Promethazine:</li><li>\u2022 first-generation antihistamine</li><li>\u2022 strong sedative properties,</li><li>\u2022 Option C. Dimehydrinate: Dimehydrinate is primarily used to prevent and treat motion sickness rather than allergic symptoms . It also has sedative effects , making it inappropriate for someone who must stay awake and alert while driving.</li><li>\u2022 Option C. Dimehydrinate:</li><li>\u2022 primarily used to prevent and treat motion sickness</li><li>\u2022 allergic symptoms</li><li>\u2022 sedative effects</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to understand the importance of selecting appropriate medications for patients with allergic symptoms , taking into consideration their daily activities and the need for alertness. In this context, second-generation antihistamines like cetirizine are preferred for individuals who require minimal impact on their cognitive function and alertness , such as those operating vehicles or heavy machinery.</li><li>\u27a4 selecting appropriate medications</li><li>\u27a4 allergic symptoms</li><li>\u27a4 daily activities</li><li>\u27a4 need for alertness.</li><li>\u27a4 second-generation antihistamines</li><li>\u27a4 cetirizine</li><li>\u27a4 require minimal impact</li><li>\u27a4 cognitive function and alertness</li><li>\u27a4 operating vehicles</li><li>\u27a4 heavy machinery.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5c87397c",
      "audio": ""
    },
    {
      "text": "Which of the following actions of drugs on the serotoninergic system is not correctly matched?",
      "options": [
        {
          "label": "A",
          "text": "Buspirone: Agonist at 5-HT1A receptors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cyproheptadine: Blocks 5-HT2A receptors",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tropisetron: 5-HT3 antagonist",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prucalopride: 5-HT1D receptor agonist",
          "correct": true
        }
      ],
      "correct_answer": "D. Prucalopride: 5-HT1D receptor agonist",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Prucalopride: 5-HT1D receptor agonist</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Buspirone: Agonist at 5-HT1A receptors - This is correctly matched . Buspirone is an anxiolytic medication that acts as a partial agonist at the 5-HT1A receptor, used primarily in the treatment of generalized anxiety disorder (GAD).</li><li>\u2022 Option A. Buspirone: Agonist at 5-HT1A receptors</li><li>\u2022 correctly matched</li><li>\u2022 Option B. Cyproheptadine: Blocks 5-HT2A receptors - This is correctly matched . Cyproheptadine is an antihistamine with additional anti-serotonergic properties, including blocking 5-HT2A receptors. It is used for various indications, including allergy symptoms and serotonin syndrome.</li><li>\u2022 Option B. Cyproheptadine: Blocks 5-HT2A receptors</li><li>\u2022 correctly matched</li><li>\u2022 Option C. Tropisetron: 5-HT3 antagonist - This is correctly matched . Tropisetron is used primarily to control nausea and vomiting caused by chemotherapy or surgery, acting as an antagonist at 5-HT3 receptors.</li><li>\u2022 Option C. Tropisetron: 5-HT3 antagonist</li><li>\u2022 correctly matched</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to understand the specific actions of various drugs on the serotoninergic system , emphasizing the importance of receptor specificity in determining the therapeutic use of these medications .</li><li>\u27a4 specific actions of various drugs</li><li>\u27a4 serotoninergic system</li><li>\u27a4 emphasizing</li><li>\u27a4 importance of receptor specificity</li><li>\u27a4 therapeutic use of these medications</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c16a6cd4",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient being treated with low dose aspirin for 6 months presented with rectal bleeding. Inhibition of which of the following substance is likely to responsible for the bleeding?",
      "options": [
        {
          "label": "A",
          "text": "TXA2",
          "correct": true
        },
        {
          "label": "B",
          "text": "LT",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bradykinin",
          "correct": false
        },
        {
          "label": "D",
          "text": "PGI2",
          "correct": false
        }
      ],
      "correct_answer": "A. TXA2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) TXA2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. LT: Leukotrienes (LT) are not primarily affected by low-dose aspirin and are more related to inflammation and bronchoconstriction.</li><li>\u2022 Option B. LT:</li><li>\u2022 Leukotrienes</li><li>\u2022 not primarily affected by low-dose aspirin</li><li>\u2022 Option C. Bradykinin: It is involved in inflammatory responses and pain ; aspirin does not significantly affect bradykinin levels.</li><li>\u2022 Option C. Bradykinin:</li><li>\u2022 involved in inflammatory responses</li><li>\u2022 pain</li><li>\u2022 Option D. PGI2: Also known as prostacyclin , is an anti-aggregatory prostanoid . While aspirin does inhibit PGI2, its predominant effect on platelets and the associated bleeding risk is through inhibition of TXA2 synthesis.</li><li>\u2022 Option D. PGI2:</li><li>\u2022 prostacyclin</li><li>\u2022 anti-aggregatory prostanoid</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to understand the mechanism of action of aspirin and its effects on platelet function , particularly its inhibition of thromboxane A2 synthesis , which reduces platelet aggregation . This antiplatelet effect is beneficial for preventing thrombosis but can also predispose to bleeding complications , underscoring the need for careful monitoring of patients on long-term aspirin therapy.</li><li>\u27a4 educational goal</li><li>\u27a4 mechanism of action</li><li>\u27a4 aspirin</li><li>\u27a4 effects on platelet function</li><li>\u27a4 inhibition of thromboxane A2 synthesis</li><li>\u27a4 reduces platelet aggregation</li><li>\u27a4 antiplatelet effect</li><li>\u27a4 preventing thrombosis</li><li>\u27a4 predispose to bleeding complications</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4bc8ac4",
      "audio": ""
    },
    {
      "text": "A 34-week pregnant female with polyhydramnios presents with labour pain. She was treated with indomethacin earlier. Which of the following can be likely outcome in the baby if delivery occurs at this time?",
      "options": [
        {
          "label": "A",
          "text": "Patent ductus arteriosus",
          "correct": false
        },
        {
          "label": "B",
          "text": "Premature closure of ductus arteriosus",
          "correct": true
        },
        {
          "label": "C",
          "text": "Patent ductus venosus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Premature closure of ductus venosus",
          "correct": false
        }
      ],
      "correct_answer": "B. Premature closure of ductus arteriosus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Premature closure of ductus arteriosus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Patent ductus arteriosus: This condition occurs when the ductus arteriosus fails to close after birth , leading to abnormal blood flow between the aorta and pulmonary artery . It is not a direct outcome of indomethacin use during pregnancy; rather, indomethacin is used to encourage the closure of a patent ductus arteriosus in the neonatal period.</li><li>\u2022 Option A. Patent ductus arteriosus:</li><li>\u2022 ductus arteriosus fails to close after birth</li><li>\u2022 abnormal blood flow</li><li>\u2022 aorta and pulmonary artery</li><li>\u2022 Option C. Patent ductus venosus: The ductus venosus is a fetal blood vessel that diverts some blood flow directly from the umbilical vein to the inferior vena cava , bypassing the liver . A patent ductus venosus after birth is unrelated to indomethacin exposure.</li><li>\u2022 Option C. Patent ductus venosus:</li><li>\u2022 ductus venosus</li><li>\u2022 fetal blood vessel that diverts some blood flow</li><li>\u2022 umbilical vein</li><li>\u2022 inferior vena cava</li><li>\u2022 bypassing the liver</li><li>\u2022 Option D. Premature closure of ductus venosus: Like the patent ductus venosus , premature closure of this vessel is not a recognized outcome of indomethacin use in pregnancy . The ductus venosus naturally closes after birth as part of the normal transition from fetal to neonatal circulation.</li><li>\u2022 Option D. Premature closure of ductus venosus:</li><li>\u2022 patent ductus venosus</li><li>\u2022 premature closure</li><li>\u2022 vessel</li><li>\u2022 not</li><li>\u2022 outcome of indomethacin</li><li>\u2022 pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational objective is to recognize the potential effects of indomethacin use during pregnancy on the fetal cardiovascular system , specifically the risk of premature closure of the ductus arteriosus . Understanding the pharmacological impacts of NSAIDs on fetal development is crucial for making informed decisions about drug use in pregnancy , highlighting the importance of weighing the benefits against potential risks when managing conditions like polyhydramnios</li><li>\u27a4 recognize the potential effects of indomethacin use</li><li>\u27a4 pregnancy on the fetal cardiovascular system</li><li>\u27a4 risk of premature closure</li><li>\u27a4 ductus arteriosus</li><li>\u27a4 pharmacological impacts of NSAIDs</li><li>\u27a4 fetal development</li><li>\u27a4 making informed decisions</li><li>\u27a4 drug use in pregnancy</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7afdeef0",
      "audio": ""
    },
    {
      "text": "After taking some drug for acute attack of migraine, a patient developed nausea and vomiting, He also developed tingling and numbness in the tip of the finger that turned blue. Which of the following is the most likely drug implicated in causing the above findings?",
      "options": [
        {
          "label": "A",
          "text": "Dihydroergotamine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Sumatriptan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Aspirin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Butorphanol",
          "correct": false
        }
      ],
      "correct_answer": "A. Dihydroergotamine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Dihydroergotamine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Sumatriptan: While Sumatriptan is indeed the drug of choice (DOC) for acute migraine attacks, it is less likely than dihydroergotamine to cause severe vasoconstriction leading to the symptoms described.</li><li>\u2022 Option B. Sumatriptan:</li><li>\u2022 drug of choice</li><li>\u2022 acute migraine attacks,</li><li>\u2022 less likely than dihydroergotamine</li><li>\u2022 cause severe vasoconstriction</li><li>\u2022 Option C. Aspirin: As a non-steroidal anti-inflammatory drug (NSAID), aspirin is used in mild to moderate migraine attacks and does not typically cause vasoconstriction or gangrene.</li><li>\u2022 Option C. Aspirin:</li><li>\u2022 non-steroidal anti-inflammatory drug</li><li>\u2022 aspirin</li><li>\u2022 mild to moderate migraine attacks</li><li>\u2022 Option D. Butorphanol: This opioid is used in severe cases of migraine where sumatriptan is not suitable. It does not typically cause the vasoconstriction associated with gangrene.</li><li>\u2022 Option D. Butorphanol:</li><li>\u2022 opioid</li><li>\u2022 used in severe cases</li><li>\u2022 migraine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dihydroergotamine, an ergot alkaloid , can cause severe vasoconstriction resulting in symptoms such as nausea, vomiting, tingling, numbness, and a bluish discoloration of the extremities due to reduced blood flow. It is contraindicated in patients with peripheral vascular disease and can lead to gangrene.</li><li>\u27a4 Dihydroergotamine,</li><li>\u27a4 ergot alkaloid</li><li>\u27a4 severe vasoconstriction</li><li>\u27a4 nausea, vomiting, tingling, numbness,</li><li>\u27a4 bluish discoloration of the extremities</li><li>\u27a4 reduced blood flow.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f441e922",
      "audio": ""
    },
    {
      "text": "Drug of choice for aborting the acute attack of severe migraine is?",
      "options": [
        {
          "label": "A",
          "text": "NSAIDs like indomethacin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Opioids like morphine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Triptans like sumatriptan",
          "correct": true
        },
        {
          "label": "D",
          "text": "Glucocorticoids",
          "correct": false
        }
      ],
      "correct_answer": "C. Triptans like sumatriptan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Triptans like sumatriptan</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. NSAIDs like indomethacin: While NSAIDs are used for mild to moderate migraine attacks, indomethacin can sometimes cause headaches and should be avoided for this condition.</li><li>\u2022 Option A. NSAIDs like indomethacin:</li><li>\u2022 mild to moderate migraine attacks,</li><li>\u2022 Option B. Opioids like morphine: Opioids are not the first choice for migraine as they can cause medication overuse headaches and other side effects.</li><li>\u2022 Option B. Opioids like morphine:</li><li>\u2022 not the first choice for migraine</li><li>\u2022 cause medication overuse headaches</li><li>\u2022 Option D. Glucocorticoids: These are not typically used for aborting acute migraine attacks , although they may be used adjunctively in certain situations.</li><li>\u2022 Option D. Glucocorticoids:</li><li>\u2022 not typically used for aborting acute migraine attacks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sumatriptan and other triptans are the drugs of choice for the acute treatment of severe migraines . NSAIDs are preferred for mild to moderate migraines, and various prophylactic medications are available for preventing migraine attacks.</li><li>\u27a4 Sumatriptan</li><li>\u27a4 triptans are the drugs of choice for the acute treatment of severe migraines</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b4b1b270",
      "audio": ""
    },
    {
      "text": "Which of the following drug acts by stimulation of 5HT4 receptors?",
      "options": [
        {
          "label": "A",
          "text": "Buspirone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Renzapride",
          "correct": true
        },
        {
          "label": "C",
          "text": "Granisetron",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metoclopramide",
          "correct": false
        }
      ],
      "correct_answer": "B. Renzapride",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Renzapride</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Buspirone - It is a 5-HT1A agonist and is primarily used for the treatment of anxiety .</li><li>\u2022 Option A. Buspirone</li><li>\u2022 5-HT1A agonist</li><li>\u2022 primarily used for the treatment of anxiety</li><li>\u2022 Option C. Granisetron - This is a 5-HT3 receptor antagonist , which is indicated for the prevention of chemotherapy-induced nausea and vomiting .</li><li>\u2022 Option C. Granisetron -</li><li>\u2022 5-HT3 receptor antagonist</li><li>\u2022 indicated for the prevention of chemotherapy-induced nausea</li><li>\u2022 vomiting</li><li>\u2022 Option D. Metoclopramide - It is an antagonist at D2 receptors and is used for its anti-emetic and prokinetic properties .</li><li>\u2022 Option D. Metoclopramide</li><li>\u2022 antagonist at D2 receptors</li><li>\u2022 anti-emetic</li><li>\u2022 prokinetic properties</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Renzapride is a 5-HT4 receptor agonist used to increase peristalsis in the gastrointestinal tract . Many 5-HT4 agonists , useful for GERD , end in 'pride' such as cisapride , mosapride , and prucalopride . It's important to note that Tegaserod, another 5-HT4 agonist, was withdrawn due to increased risk of myocardial infarction.</li><li>\u2022 Renzapride is a 5-HT4 receptor agonist</li><li>\u2022 increase peristalsis in the gastrointestinal tract</li><li>\u2022 5-HT4 agonists</li><li>\u2022 GERD</li><li>\u2022 end in 'pride' such as cisapride</li><li>\u2022 mosapride</li><li>\u2022 prucalopride</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9aed9be",
      "audio": ""
    },
    {
      "text": "Rasburicase is an analogue of:",
      "options": [
        {
          "label": "A",
          "text": "Xanthine oxidase",
          "correct": false
        },
        {
          "label": "B",
          "text": "IMP dehydrogenase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Adenosine deaminase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urate oxidase",
          "correct": true
        }
      ],
      "correct_answer": "D. Urate oxidase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Urate oxidase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Rasburicase is an enzyme that acts as a recombinant version of urate oxidase , an enzyme that catalyzes the oxidation of uric acid to allantoin , which is more soluble and easily excreted by the kidneys . This mechanism makes rasburicase an effective treatment for preventing or reducing hyperuricemia (high levels of uric acid in the blood) associated with tumor lysis syndrome , which can occur after the initiation of cancer treatment.</li><li>\u2022 Rasburicase</li><li>\u2022 enzyme</li><li>\u2022 acts as a recombinant version of urate oxidase</li><li>\u2022 enzyme that catalyzes the oxidation</li><li>\u2022 uric acid to allantoin</li><li>\u2022 more soluble</li><li>\u2022 excreted by the kidneys</li><li>\u2022 mechanism makes rasburicase</li><li>\u2022 effective treatment for preventing</li><li>\u2022 reducing hyperuricemia</li><li>\u2022 tumor lysis syndrome</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to understand the mechanism of action of rasburicase and its role in the management of hyperuricemia , particularly in the context of tumor lysis syndrome . Recognizing rasburicase as a urate oxidase analogue helps in understanding its utility in converting uric acid to allantoin , thus facilitating its excretion and preventing the complications of high uric acid levels.</li><li>\u27a4 mechanism of action of rasburicase</li><li>\u27a4 role in the management of hyperuricemia</li><li>\u27a4 tumor lysis syndrome</li><li>\u27a4 rasburicase</li><li>\u27a4 urate oxidase analogue</li><li>\u27a4 understanding its utility</li><li>\u27a4 converting uric acid to allantoin</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3baa2a02",
      "audio": ""
    },
    {
      "text": "Drug X shown in the figure represents:",
      "options": [
        {
          "label": "A",
          "text": "Colchicine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rasburicase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Allopurinol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Probenecid",
          "correct": false
        }
      ],
      "correct_answer": "C. Allopurinol",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture11.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Allopurinol</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Allopurinol is a medication that inhibits xanthine oxidase , an enzyme involved in the purine catabolism pathway that converts hypoxanthine to xanthine and xanthine to uric acid. By inhibiting this enzyme , allopurinol decreases the production of uric acid, making it an effective treatment for chronic gout and hyperuricemia . The image shows allopurinol (Drug X) as an inhibitor at the step where xanthine oxidase catalyzes the conversion of hypoxanthine to xanthine and xanthine to uric acid.</li><li>\u2022 Allopurinol</li><li>\u2022 medication that inhibits xanthine oxidase</li><li>\u2022 enzyme</li><li>\u2022 purine catabolism pathway</li><li>\u2022 converts hypoxanthine to xanthine</li><li>\u2022 xanthine to uric acid.</li><li>\u2022 inhibiting this enzyme</li><li>\u2022 allopurinol decreases</li><li>\u2022 production of uric acid,</li><li>\u2022 effective treatment for chronic gout and hyperuricemia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to understand the site of action of medications used in the management of gout and hyperuricemia . Recognizing that allopurinol acts as a xanthine oxidase inhibitor helps in understanding how it reduces uric acid levels and prevents the formation of urate crystals , which are responsible for the inflammation and pain associated with gout.</li><li>\u27a4 site of action of medications used in the management of gout</li><li>\u27a4 hyperuricemia</li><li>\u27a4 allopurinol acts as a xanthine oxidase inhibitor</li><li>\u27a4 understanding how it reduces uric acid levels</li><li>\u27a4 prevents the formation of urate crystals</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d9332ce2",
      "audio": ""
    },
    {
      "text": "A 60-year-old female with renal disease was admitted for pyelolithotomy. Postoperative analgesic of choice in this patient is?",
      "options": [
        {
          "label": "A",
          "text": "Diclofenac",
          "correct": false
        },
        {
          "label": "B",
          "text": "Indomethacin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Naproxen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acetaminophen",
          "correct": true
        }
      ],
      "correct_answer": "D. Acetaminophen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Acetaminophen</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Diclofenac : NSAID with potential nephrotoxic effects , especially harmful in patients with renal impairment.</li><li>\u2022 Option A. Diclofenac</li><li>\u2022 NSAID</li><li>\u2022 potential nephrotoxic effects</li><li>\u2022 Option B. Indomethacin :  Another NSAID that can affect renal prostaglandin production and impair renal function.</li><li>\u2022 Option B. Indomethacin</li><li>\u2022 NSAID</li><li>\u2022 affect renal prostaglandin production</li><li>\u2022 Option C. Naproxen: Also an NSAID that may exacerbate renal issues due to its effect on renal blood flow and prostaglandin synthesis .</li><li>\u2022 Option C. Naproxen:</li><li>\u2022 NSAID</li><li>\u2022 exacerbate renal issues</li><li>\u2022 effect on renal blood flow</li><li>\u2022 prostaglandin synthesis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to recognize the appropriate postoperative analgesic in patients with renal disease . Acetaminophen is generally considered safe for renal patients , as it provides effective pain relief without the renal risks associated with NSAIDs . This knowledge is important for preventing potential renal complications in patients with compromised kidney function.</li><li>\u27a4 appropriate postoperative analgesic</li><li>\u27a4 renal disease</li><li>\u27a4 Acetaminophen</li><li>\u27a4 safe for renal patients</li><li>\u27a4 effective pain relief without the renal risks</li><li>\u27a4 NSAIDs</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b9d2d426",
      "audio": ""
    },
    {
      "text": "All of the following drugs are used for prophylaxis of migraine except?",
      "options": [
        {
          "label": "A",
          "text": "Sumatriptan",
          "correct": true
        },
        {
          "label": "B",
          "text": "Valproate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Propranolol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Topiramate",
          "correct": false
        }
      ],
      "correct_answer": "A. Sumatriptan",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-110553.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Sumatriptan</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Valproate: This anti-epileptic drug is also used for migraine prophylaxis due to its ability to stabilize neuronal membranes .</li><li>\u2022 Option B. Valproate:</li><li>\u2022 anti-epileptic drug</li><li>\u2022 migraine prophylaxis</li><li>\u2022 ability to stabilize neuronal membranes</li><li>\u2022 Option C. Propranolol: This beta-blocker is considered the drug of choice for migraine prophylaxis as it can prevent the vasodilation that contributes to migraine headaches.</li><li>\u2022 Option C. Propranolol:</li><li>\u2022 beta-blocker</li><li>\u2022 drug of choice for migraine prophylaxis</li><li>\u2022 prevent the vasodilation</li><li>\u2022 Option D. Topiramate: Another anti-epileptic drug that is effective in reducing the frequency of migraine headaches.</li><li>\u2022 Option D. Topiramate:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Sumatriptan is used for the treatment of acute severe migraine attacks and not for prophylaxis. For migraine prophylaxis, medications such as Valproate, Propranolol, and Topiramate are used.</li><li>\u27a4 Sumatriptan</li><li>\u27a4 treatment of acute severe migraine attacks</li><li>\u27a4 Drugs used in prophylaxis of migraine are:</li><li>\u27a4 Drugs used in prophylaxis of migraine are:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2a7d5619",
      "audio": ""
    },
    {
      "text": "Drug Y shown in figure represents:",
      "options": [
        {
          "label": "A",
          "text": "Colchicine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rasburicase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Allopurinol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Probenecid",
          "correct": false
        }
      ],
      "correct_answer": "B. Rasburicase",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture21.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Rasburicase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Colchicine :  It is used in the treatment of gout , not as a urate-lowering agent, but to alleviate inflammation.</li><li>\u2022 Option A. Colchicine</li><li>\u2022 used in the treatment of gout</li><li>\u2022 Option C. Allopurinol: It works by inhibiting xanthine oxidase , thereby preventing the formation of uric acid from xanthine and hypoxanthine.</li><li>\u2022 Option C. Allopurinol:</li><li>\u2022 inhibiting xanthine oxidase</li><li>\u2022 preventing the formation of uric acid from xanthine</li><li>\u2022 Option D. Probenecid: This drug acts by increasing the renal excretion of uric acid but does not directly convert uric acid to allantoin.</li><li>\u2022 Option D. Probenecid:</li><li>\u2022 drug acts by increasing the renal excretion of uric acid</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The goal is to understand the role of rasburicase in the management of hyperuricemia , especially in the acute setting of tumor lysis syndrome . Knowledge of rasburicase\u2019s mechanism of action is essential for recognizing its value in lowering elevated uric acid levels quickly to prevent renal damage and other serious complications.</li><li>\u27a4 role of rasburicase</li><li>\u27a4 management of hyperuricemia</li><li>\u27a4 acute setting of tumor lysis syndrome</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0616ef15",
      "audio": ""
    },
    {
      "text": "A person is planning a road trip from Chandigarh to Manali. He developed severe vomiting during his last trip to Manali. Which of the following drug should be taken by the person to avoid the motion sickness?",
      "options": [
        {
          "label": "A",
          "text": "Fexofenadine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cetirizine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Loratadine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Promethazine",
          "correct": true
        }
      ],
      "correct_answer": "D. Promethazine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-154406.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Promethazine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Fexofenadine: A second-generation antihistamine primarily used for allergies, not effective for motion sickness due to lack of anti-cholinergic properties.</li><li>\u2022 Option A. Fexofenadine:</li><li>\u2022 second-generation antihistamine</li><li>\u2022 used for allergies,</li><li>\u2022 Option B. Cetirizine: Similar to Fexofenadine, it is a second-generation antihistamine that is not used for motion sickness.</li><li>\u2022 Option B. Cetirizine:</li><li>\u2022 second-generation antihistamine</li><li>\u2022 Option C. Loratadine: Also a second-generation antihistamine with little to no anti-cholinergic activity, and thus not recommended for motion sickness.</li><li>\u2022 Option C. Loratadine:</li><li>\u2022 second-generation antihistamine</li><li>\u2022 little to no anti-cholinergic activity,</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 First-generation antihistamines, like Promethazine, can cross the blood-brain barrier and cause sedation, have anti-cholinergic side effects , and are useful in treating various conditions including allergies, motion sickness, drug-induced parkinsonism, muscular dystonias, and the common cold. In contrast, second-generation antihistamines, such as Fexofenadine, Cetirizine, and Loratadine, do not cross the blood-brain barrier, generally do not cause sedation , do not have anti-cholinergic activity , and are primarily useful for allergies.</li><li>\u27a4 First-generation antihistamines,</li><li>\u27a4 Promethazine,</li><li>\u27a4 cross the blood-brain barrier</li><li>\u27a4 sedation,</li><li>\u27a4 anti-cholinergic side</li><li>\u27a4 effects</li><li>\u27a4 treating</li><li>\u27a4 allergies, motion sickness, drug-induced parkinsonism, muscular dystonias,</li><li>\u27a4 common cold.</li><li>\u27a4 second-generation antihistamines,</li><li>\u27a4 Fexofenadine, Cetirizine,</li><li>\u27a4 Loratadine,</li><li>\u27a4 not cross the blood-brain barrier,</li><li>\u27a4 not cause sedation</li><li>\u27a4 not have anti-cholinergic activity</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "db43dd29",
      "audio": ""
    },
    {
      "text": "Etanercept is a disease-modifying drug used in management of rheumatoid arthritis. What is its mechanism of action?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of TNF alpha",
          "correct": true
        },
        {
          "label": "B",
          "text": "COX-2 inhibition",
          "correct": false
        },
        {
          "label": "C",
          "text": "IL-6 inhibition",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stabilization of mast cells",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of TNF alpha",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-105644.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Inhibition of TNF alpha</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. COX-2 inhibition: COX-2 inhibitors are a class of nonsteroidal anti-inflammatory drugs (NSAIDs) that specifically inhibit the cyclooxygenase-2 enzyme , reducing pain and inflammation. This mechanism is not related to etanercept's action.</li><li>\u2022 Option B. COX-2 inhibition:</li><li>\u2022 class of nonsteroidal anti-inflammatory drugs</li><li>\u2022 inhibit the cyclooxygenase-2 enzyme</li><li>\u2022 reducing pain</li><li>\u2022 inflammation.</li><li>\u2022 Option C. IL-6 inhibition: IL-6 inhibitors, such as tocilizumab, target the interleukin-6 (IL-6) cytokine, another key player in the inflammatory process of rheumatoid arthritis. While IL-6 inhibition is a valid therapeutic approach, it is not the mechanism by which etanercept works.</li><li>\u2022 Option C. IL-6 inhibition:</li><li>\u2022 tocilizumab, target the interleukin-6</li><li>\u2022 inflammatory process of rheumatoid arthritis.</li><li>\u2022 Option D. Stabilization of mast cells: Mast cell stabilizers inhibit the release of histamine and other mediators from mast cells , which are involved in allergic reactions , rather than the inflammatory processes central to rheumatoid arthritis. Etanercept does not act by stabilizing mast cells.</li><li>\u2022 Option D. Stabilization of mast cells:</li><li>\u2022 inhibit the release of histamine</li><li>\u2022 other mediators from mast cells</li><li>\u2022 involved in allergic reactions</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to understand the specific mechanisms of action of biologic DMARDs, particularly etanercept , in the management of rheumatoid arthritis . Recognizing that etanercept inhibits TNF alpha highlights the importance of targeted therapies in controlling inflammation and preventing joint damage in autoimmune diseases.</li><li>\u27a4 specific mechanisms of action of biologic DMARDs,</li><li>\u27a4 etanercept</li><li>\u27a4 management of rheumatoid arthritis</li><li>\u27a4 etanercept inhibits TNF alpha</li><li>\u27a4 importance of targeted therapies</li><li>\u27a4 controlling inflammation</li><li>\u27a4 preventing joint damage</li><li>\u27a4 autoimmune diseases.</li><li>\u27a4 Biological Disease Modifying Anti Rheumatoid Drugs</li><li>\u27a4 Biological Disease Modifying Anti Rheumatoid Drugs</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "496a75fa",
      "audio": ""
    },
    {
      "text": "Which of the following statements about Colchicine is true?",
      "options": [
        {
          "label": "A",
          "text": "Acts by inhibiting granulocyte migration in the joint.",
          "correct": false
        },
        {
          "label": "B",
          "text": "It causes metaphase arrest",
          "correct": false
        },
        {
          "label": "C",
          "text": "It can result in myopathy as an adverse effect.",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) All of the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Acts by inhibiting granulocyte migration in the joint. Colchicine exerts its anti-inflammatory effects in part by inhibiting granulocyte (a type of white blood cell) migration to the site of inflammation , which is particularly relevant in the treatment of gout, where granulocytes contribute to the inflammatory response in joints.</li><li>\u2022 Option A. Acts by inhibiting granulocyte migration in the joint.</li><li>\u2022 Colchicine</li><li>\u2022 anti-inflammatory effects</li><li>\u2022 inhibiting granulocyte</li><li>\u2022 migration</li><li>\u2022 site of inflammation</li><li>\u2022 Option B. It causes metaphase arrest. Colchicine binds to tubulin , a protein that is essential for microtubule formation . By inhibiting microtubule polymerization , colchicine disrupts mitosis at the metaphase stage , which contributes to its anti-inflammatory effects but also accounts for its toxicity in rapidly dividing cells.</li><li>\u2022 Option B. It causes metaphase arrest.</li><li>\u2022 Colchicine binds to tubulin</li><li>\u2022 protein</li><li>\u2022 microtubule formation</li><li>\u2022 inhibiting microtubule polymerization</li><li>\u2022 colchicine disrupts mitosis</li><li>\u2022 metaphase stage</li><li>\u2022 Option C. It can result in myopathy as an adverse effect. Colchicine can cause myopathy , a muscle disease , as an adverse effect, particularly when used in high doses or in patients with renal impairment or when used in combination with other drugs known to increase the risk of myopathy.</li><li>\u2022 Option C. It can result in myopathy as an adverse effect.</li><li>\u2022 Colchicine can cause myopathy</li><li>\u2022 muscle disease</li><li>\u2022 adverse effect,</li><li>\u2022 used in high doses</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to understand the pharmacology of colchicine , including its mechanisms of action and potential adverse effects . Recognizing the broad effects of colchicine is crucial for its safe and effective use in clinical practice, especially in the management of gout and for the potential risks associated with its use, such as myopathy.</li><li>\u27a4 pharmacology of colchicine</li><li>\u27a4 mechanisms of action</li><li>\u27a4 potential adverse effects</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e857fd70",
      "audio": ""
    },
    {
      "text": "Gout is precipitated by all except?",
      "options": [
        {
          "label": "A",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pyrazinamide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thiazides",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sulfinpyrazone",
          "correct": true
        }
      ],
      "correct_answer": "D. Sulfinpyrazone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Sulfinpyrazone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Furosemide: This is a loop diuretic that can lead to increased uric acid levels in the blood by competing with uric acid for excretion in the renal tubules, which can precipitate gout.</li><li>\u2022 Option A. Furosemide:</li><li>\u2022 loop diuretic</li><li>\u2022 lead to increased uric acid levels</li><li>\u2022 blood by competing with uric acid</li><li>\u2022 Option B. Pyrazinamide: This antitubercular medication can cause hyperuricemia by reducing renal excretion of uric acid , which can precipitate gout.</li><li>\u2022 Option B. Pyrazinamide:</li><li>\u2022 antitubercular medication</li><li>\u2022 hyperuricemia</li><li>\u2022 reducing renal excretion of uric acid</li><li>\u2022 Option C. Thiazides: These diuretics can also increase uric acid levels by similar mechanisms to furosemide , which can lead to gout flare-ups.</li><li>\u2022 Option C. Thiazides:</li><li>\u2022 diuretics</li><li>\u2022 increase uric acid levels</li><li>\u2022 mechanisms to furosemide</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to recognize the medications that can precipitate gout by increasing uric acid levels and to differentiate them from those that are used to treat gout.</li><li>\u27a4 recognize the medications</li><li>\u27a4 precipitate gout by increasing uric acid levels</li><li>\u27a4 differentiate</li><li>\u27a4 used to treat gout.</li><li>\u27a4 Drugs that cause Hyperuricemia</li><li>\u27a4 Drugs that cause Hyperuricemia</li><li>\u27a4 Alcohol Thiazides Loop diuretics (Furosemide, Torsemide etc.) Salicylates Pyrazinamide Ethambutol Nicotinic acid Cyclosporine Cytotoxic anticancer drugs</li><li>\u27a4 Alcohol</li><li>\u27a4 Thiazides</li><li>\u27a4 Loop diuretics (Furosemide, Torsemide etc.)</li><li>\u27a4 Salicylates</li><li>\u27a4 Pyrazinamide</li><li>\u27a4 Ethambutol</li><li>\u27a4 Nicotinic acid</li><li>\u27a4 Cyclosporine</li><li>\u27a4 Cytotoxic anticancer drugs</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "97c10cfc",
      "audio": ""
    },
    {
      "text": "Pegloticase is used in treatment of:",
      "options": [
        {
          "label": "A",
          "text": "Chronic tophaceous gout",
          "correct": true
        },
        {
          "label": "B",
          "text": "Paralytic ileus",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rheumatoid arthritis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Psoriatic arthritis",
          "correct": false
        }
      ],
      "correct_answer": "A. Chronic tophaceous gout",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture4.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Chronic tophaceous gout</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Paralytic ileus: Pegloticase is not used for treating gastrointestinal conditions like paralytic ileus.</li><li>\u2022 Option B. Paralytic ileus:</li><li>\u2022 not</li><li>\u2022 treating gastrointestinal conditions</li><li>\u2022 Option C. Rheumatoid arthritis: While also a form of arthritis, rheumatoid arthritis is not treated with pegloticase.</li><li>\u2022 Option C. Rheumatoid arthritis:</li><li>\u2022 form of arthritis,</li><li>\u2022 Option D. Psoriatic arthritis : This type of arthritis , associated with psoriasis , is not an indication for pegloticase therapy.</li><li>\u2022 Option D. Psoriatic arthritis</li><li>\u2022 type of arthritis</li><li>\u2022 psoriasis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pegloticase is an enzyme therapy used in the treatment of chronic tophaceous gout , particularly in patients who have failed conventional therapy . It catalyzes the conversion of uric acid to allantoin, facilitating the reduction of uric acid levels in the body.</li><li>\u27a4 Pegloticase</li><li>\u27a4 enzyme therapy</li><li>\u27a4 treatment of chronic tophaceous gout</li><li>\u27a4 failed conventional therapy</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b9380e78",
      "audio": ""
    },
    {
      "text": "Which of the following antihistamines has minimal or no CNS depressant activity?",
      "options": [
        {
          "label": "A",
          "text": "Promethazine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Meclizine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cinnarizine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fexofenadine",
          "correct": true
        }
      ],
      "correct_answer": "D. Fexofenadine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-110939.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Fexofenadine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Promethazine: A first-generation antihistamine with sedative properties .</li><li>\u2022 Option A. Promethazine:</li><li>\u2022 first-generation antihistamine</li><li>\u2022 sedative properties</li><li>\u2022 Option B. Meclizine :  Another first-generation antihistamine that can cause sedation .</li><li>\u2022 Option B. Meclizine</li><li>\u2022 first-generation antihistamine</li><li>\u2022 cause sedation</li><li>\u2022 Option C. Cinnarizine :  Also a first-generation antihistamine with CNS depressant effects .</li><li>\u2022 Option C. Cinnarizine</li><li>\u2022 first-generation antihistamine</li><li>\u2022 CNS depressant effects</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Fexofenadine is a second-generation antihistamine with minimal to no CNS depressant activity . It is selective for the H1 receptor and does not have significant anticholinergic activity or additional anti-allergic mechanisms beyond histamine blockade , unlike first-generation antihistamines which can cause sedation as they cross the blood-brain barrier.</li><li>\u2022 Fexofenadine</li><li>\u2022 second-generation antihistamine</li><li>\u2022 minimal to no CNS depressant activity</li><li>\u2022 selective for the H1 receptor</li><li>\u2022 does not</li><li>\u2022 anticholinergic activity</li><li>\u2022 anti-allergic mechanisms</li><li>\u2022 histamine blockade</li><li>\u2022 first-generation antihistamines</li><li>\u2022 cause sedation</li><li>\u2022 H 1 ANTIHISTAMINES</li><li>\u2022 H 1 ANTIHISTAMINES</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "997ac748",
      "audio": ""
    }
  ]
}